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ABSTRACT 
 Phosphite dehydrogenase (PTDH) catalyzes the oxidation of phosphite to phosphate with 
the concurrent reduction of NAD+ to NADH. The mechanism of the reaction resembles a 
phosphoryl transfer reaction. A nucleophilic displacement reaction occurs on the phosphoryl 
group, with water or hydroxide attacking the phosphorus atom and hydride acting as the leaving 
group. Given the inherently poor nature of the hydride leaving group, PTDH presents a case of 
an enzyme catalyzing unusual chemistry.  
Although PTDH activity was initially believed to be unique to the enzyme from 
Pseudomonas stutzeri, searches of the protein databases have uncovered genes with high 
sequence identity to the original PTDH. When diverse members of this family were expressed 
and the purified proteins characterized, it was revealed that several orthologs of PTDH were able 
to catalyze the PTDH reaction with similar catalytic parameters. Sequence alignments of the 
PTDH orthologs showed that numerous enzyme residues are conserved amongst the PTDH 
family. In conjunction with the recently solved X-ray crystal structure of PTDH, several 
conserved residues that are present in the active site were identified and studied by mutagenesis 
experiments.  
Arg301 is conserved among known PTDHs and is in good position in the active site to act as 
the catalytic base in the reaction. Arg301 is important for efficient catalysis, as the Arg301Ala 
mutant displayed an approximately 100-fold decrease in kcat, and an approximately 700-fold 
increase in Km,phosphite. Chemical rescue and pH dependence experiments suggested that Arg301 
acts as a positively charged residue in electrostatic activation of the reaction, rather than acting as 
the base. In addition, inhibition experiments indicated that binding of the sulfite competitive 
inhibitor in mutants of Arg301 was greatly decreased, suggesting that Arg301 plays an important 
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role in substrate binding. The crystal structures of the Arg301Ala and Arg301Lys mutants of 
PTDH have been solved, and they are consistent with these proposed roles.   
In proteins, methionine residues are most commonly associated with hydrophobic 
interactions and steric effects. However, in the crystal structure of PTDH ternary complex, the 
sulfur of the conserved Met53 appears to interact with an oxygen atom on the sulfite competitive 
inhibitor. Mutagenesis experiments showed that Met53 is important for catalysis; mutations of 
this residue resulted in significantly decreased kcat, without changing Km for phosphite. A 
computational quantum mechanics/molecular mechanics (QM/MM) model was developed by the 
Mulholland Laboratory (University of Bristol, UK), which proposed that the side chain of Met53 
stabilizes the transition state for hydride transfer during the PTDH reaction through an nπ* 
interaction between the Met53 sulfur and the His292 imidazolium. This hypothesis was 
supported by the experimental data, which indicated that mutation of Met53 affects the rate-
limiting hydride transfer step in the reaction.  
In addition, a library of PTDH mutants was generated in an attempt to generate a PTDH 
capable of accepting thiophosphite as an alternative substrate through directed evolution. Several 
preliminary hits in this assay are currently being investigated. Successful mutation could allow 
for future analysis of the stereochemistry of the PTDH reaction. Attempts have also been made 
to determine if PTDH uses a covalent catalysis mechanism during phosphoryl transfer by 
detecting a phosphohistidine adduct using mass spectrometry.  
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CHAPTER 1: INTRODUCTION 
 
1.1 The Reaction Catalyzed by Phosphite Dehydrogenase 
Phosphite dehydrogenase (PTDH) endows microorganisms with the ability to grow using 
phosphite as the sole source of phosphorus (1). This enzyme was first discovered in 
Pseudomonas stutzeri WM88, an organism that was identified as an efficient oxidizer of reduced 
phosphorus compounds, with the ability to grow on both phosphite and hypophosphite (2, 3). 
PTDH catalyzes the oxidation of phosphite to phosphate with the concurrent reduction of NAD+ 
to NADH (Scheme 1.1). The reaction resembles a phosphoryl transfer process in which water or 
hydroxide acts as the phosphoryl acceptor and hydride acts as the phosphoryl donor. Thus, this 
reaction presents an unusual example of an enzyme catalyzing a nucleophilic displacement 
reaction with a hydride leaving group. Indeed, deuterium-labeling studies have confirmed that 
the hydride group is transferred directly from phosphite to NADH (4). Although at first glance 
the reaction would appear to be an unfavorable process, analysis of the thermodynamics of the 
reaction indicates it is actually 15 kcal/mol exergonic (4). 
 
 
Scheme 1.1 
 
 
Reproduced in part with permission from: Hung, J. E., Fogle, E. J., Christman, H. D., Johannes, T. W., 
Zhao, H. M., Metcalf, W. W., and van der Donk, W. A. (2012) Investigation of the Role of Arg301 
Identified in the X-ray Structure of Phosphite Dehydrogenase, Biochemistry 51, 4254-4262. Copyright 
2012 American Chemical Society.  
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Given the unusual nature of this reaction, significant experimental effort has been put into 
understanding how the enzyme catalyzes this chemistry (4-8). The enzyme follows an ordered 
kinetic mechanism with NAD+ binding before phosphite (1). Kinetic isotope effect (KIE) studies 
with deuterium-labeled phosphite and pre-steady state kinetic studies have shown that hydride 
transfer is fully rate-limiting for the PTDH reaction (6, 9). PTDH shares ~25-40% sequence 
identity with the family of D-hydroxy acid dehydrogenases (DHDHs) (10), including several 
residues that have well defined roles in these enzymes. Site-directed mutagenesis studies on 
these amino acids have provided some insights into the mechanism of phosphite oxidation (5, 6), 
but many questions still remain. Recent reports have shown that a number of organisms encode 
enzymes with PTDH activity (7, 11-13). Analysis of their amino acid sequences suggests that 
PTDHs consist of their own branch of the DHDH family and has allowed the investigation of 
residues that are conserved among PTDHs but not the DHDHs (see Chapter 2).  
 
1.2 Variants of PTDH as a Cofactor Regeneration System 
PTDH has been adapted for use in cofactor regeneration strategies to recycle catalytic pools 
of NADH (14). NADH and its phosphorylated analog NADPH are commonly used as 
stoichiometric hydride donors in biotechnology (15), and although the enzymes that utilize these 
cofactors are highly efficient and selective, the cofactors are quite expensive. As of this writing, 
the cost of NADH is $80/mmol while NADPH is $4500/mmol (Sigma Aldrich). Although other 
NADH-regeneration systems are available (16, 17), PTDH is uniquely useful due to the high 
thermodynamic driving force behind the reaction and the inexpensive sacrificial reductant 
utilized, phosphite ($17.70/mol, Sigma Aldrich).  
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Variants of PTDH have been engineered with relaxed cofactor specificity (18), using 
homology models to rationally design an enzyme capable of accepting NADP as a substrate. In 
addition, directed evolution studies via error-prone polymerase chain reaction (PCR) have 
developed mutants with increased activity (19) and greatly increased thermostability (20), 
yielding an enzyme with a half-life of nearly six days at 45 °C. This variant is the most versatile 
for cofactor regeneration, and is termed 17X-PTDH due to its 17 amino acid mutations from the 
wild-type. 17X-PTDH contains 12 mutations that result in considerably increased thermostability 
with minimal change in activity, and 4 additional mutations that increase its activity. An 
additional E175A mutation confers on the enzyme the ability to utilize both NAD+ and NADP. 
The kinetic isotope effects, pH dependence, and pre-steady state kinetics observed with 17X-
PTDH are all very similar to those observed with wild-type (wt) PTDH (9), suggesting that these 
two proteins use the same mechanism of catalysis. 
In addition to general cofactor regeneration, other uses for PTDH have been developed and 
reported in the literature. PTDH with dual cofactor specificity has been fused to flavin 
monooxygenases and the resulting self-sufficient biocatalysts have been demonstrated to have 
excellent activities for enantioselective catalysis (21-24).  PTDH has also found use in 
fluorescence assays to quantify phosphite concentrations in plants (25). 
 
1.3 Previous Insights into the PTDH Mechanism 
In an effort to identify how PTDH achieves catalysis, several highly conserved residues that 
are shared between members of the DHDH family and PTDH were identified, and their roles in 
the PTDH reaction studied through mutagenesis (5, 6, 9). One residue of particular interest is 
His292 (PTDH numbering); in the DHDHs, this conserved histidine is proposed to act as a 
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catalytic base that deprotonates the alcohol substrate and as an acid that protonates the carbonyl 
in the reverse reaction (26). In PTDH, mutation of this residue completely abolished activity, and 
covalent modification of the residue with diethylpyrocarbonate (DEPC) led to complete 
inactivation of the wild-type (wt) enzyme (5). Given its catalytic importance, His292 was 
proposed to be the active site base that deprotonates the water nucleophile in the PTDH reaction. 
However, no direct experimental evidence has been obtained to confirm this hypothesis. Two 
other conserved residues that act in DHDH catalysis (27, 28), Glu266 and Arg237, were reported 
to play roles in PTDH by helping to position His292 and modulate its pKa, and by binding the 
phosphite substrate, respectively (5).  
The pH rate profile provided further insight into catalysis. For wt-PTDH, the pH rate profile 
for log(kcat/Km,phosphite) shows a bell-shaped curve indicating that for optimal catalysis one group 
(on the protein or the substrate) must be deprotonated and another group must be protonated (6). 
The pKa values deduced from the curve are 6.8 and 7.8, respectively. The lower pKa corresponds 
well to the second acid dissociation constant of phosphorous acid (the conjugate acid of 
phosphite) suggesting that the enzyme may utilize the dianionic form of the substrate. The higher 
pKa would then correspond to an enzyme residue that must be protonated. The pH dependence of 
DEPC inactivation tentatively suggests that this limb corresponds to His292 (29), but if so it 
could not be the catalytic base that deprotonates the water nucleophile. One scenario that would 
still allow His292 to serve as base involves binding of dianionic phosphite to PTDH with a 
protonated His292, followed by proton transfer from His292 to phosphite in the ternary complex 
because of perturbed pKa values in the ternary complex (Figure 1.1). An alternative interpretation 
of the data is that phosphite must be protonated and His292 deprotonated for substrate binding. 
In this interpretation, the minor, monoprotonated form of the substrate at the optimal pH of 7.25 
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would bind to the minor form of the enzyme with a deprotonated His (Figure 1.1). Such a reverse 
protonation scenario would result in an identical pH-rate profile because both of these two 
protonation states of the substrate and enzyme would have maximum occupancy at pH 7.25, 
falling off at both higher and lower pH values (6). Because the pKa values of the acidic and basic 
limbs of the PTDH pH rate profile have less than 2 pH units in separation, it is difficult to 
differentiate between normal and reverse protonation states (30). 
 
Figure 1.1. Possible protonation states of phosphite and His292 in PTDH. The two substrates bind to the 
enzyme in an ordered mechanism with NAD+ binding first (1). Based on the pH-rate profile, dianionic 
phosphite could bind to the NAD+-PTDH complex containing a protonated His292 (blue). If this is the 
active complex, a residue other than His292 must function as base to deprotonate the water nucleophile. 
Alternatively, the pKa values of phosphite and the His could be perturbed in the ternary complex such that 
a proton transfer takes place from the protonated His to the phosphite to generate a monoprotonated 
phosphite as the actual electrophile (red). This form of the ternary complex could also be accessed if 
monoanionic phosphite binds to the NAD+-PTDH complex in which the His is unprotonated (reverse 
protonation based on their pKa values). Reprinted with permission from (7). 
 
The mechanism of phosphoryl transfer for the PTDH reaction is also unverified. Four 
potential mechanisms have been discussed (8). One possibility is a concerted SN2-like 
mechanism in which water or hydroxide attacks the phosphorus of phosphite and the hydride 
leaving group is transferred to NAD+ (Figure 1.2A). However, the solvent isotope effect (SIE) 
and substrate kinetic isotope effect (KIE) are not multiplicative, suggesting that a multi-step 
mechanism is operational instead (6).  
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Alternatively, an associative mechanism is possible in which the nucleophile attacks prior to 
hydride group departure, resulting in a pentavalent phosphorane intermediate (Figure 1.2B). A 
dissociative mechanism could also take place in which the hydride group leaves prior to attack 
by the nucleophile, forming a trivalent metaphosphate intermediate (Figure 1.2C). The viability 
of the metaphosphate moiety as a stable intermediate in solution has been debated (31, 32), 
though the species has been putatively observed in the crystal structure of fructose 1,6 
bisphosphatase (33). Finally, a covalent catalysis mechanism is possible in which a catalytic 
residue attacks phosphite to form a covalent intermediate (Figure 1.2D, see Appendix A). Like 
the mechanisms in panels A-C, the first step of a covalent mechanism could be concerted (as 
shown in panel D), associative, or dissociative. In addition to the uncertain mechanism of 
phosphoryl transfer, the timing of deprotonation of the water nucleophile is unresolved and could 
occur before, during or after nucleophilic attack. 
 
Figure 1.2. Potential mechanisms of phosphoryl transfer by PTDH: A) concerted, B) associative, 
C) dissociative, and D) covalent catalysis 
 
 1.4 The P
The c
A co-cry
phosphite
4E5K). T
allows 17
PTDH sh
proceed t
Figure 1
are the c
newly ide
 
In the
close pro
designate
TDH Crys
rystal struct
stal structur
 (4), is ava
S-PTDH d
X-PTDH to
ow very si
hrough the 
.3. Depictio
onserved ac
ntified resid
 crystal stru
ximity to s
d by the m
tal Structu
ures of seve
e of TS-PTD
ilable, whic
iffers from 
 use both N
milar positi
same mecha
n of the acti
tive site re
ue Arg301 
cture of the
ulfite. The 
utagenesis 
re 
ral thermos
H with NA
h depicts th
17X-PTDH 
AD+ and N
ons of activ
nism of cata
ve site of T
sidues His2
(see Chapte
 enzyme act
X-ray stru
studies. Ar
7 
table PTDH
D+ and sul
e ternary str
only throug
ADP. The 
e site resid
lysis.  
S-PTDH wi
92, Glu266
r 2).  
ive site, His
cture suppo
g237 indeed
 variants hav
fite, which i
ucture of th
h the lack
X-ray struct
ues (34), an
th NAD+ an
, and Arg2
292, Glu26
rts the role
 appears to
e recently b
s a competi
e enzyme (F
of the E175
ures of 17X
d it is very
 
d sulfite bo
37. Shown 
6, and Arg2
s of the re
 be playin
een solved
tive inhibito
igure 1.3, P
A mutation
-PTDH and
 likely that
und. Also sh
in yellow i
37 are locat
sidues that 
g a role to 
(34). 
r for 
DB: 
 that 
 TS-
 they 
own 
s the 
ed in 
were 
bind 
8 
 
phosphite, while His292 is in good distance and orientation to a crystallographic water molecule 
that would allow it to act as a base. Glu266 is hydrogen bonded to the Nδ1 nitrogen of the 
His292 imidazole, and appears to play a stabilizing role. The 16 mutations from wt-PTDH were 
revealed to be far from the PTDH active site, and they are unlikely to play direct roles in 
catalysis (34).  
The crystal structure also revealed that another residue, Arg301, is within hydrogen bonding 
distance of a water molecule adjacent to sulfite, in a position that would allow it to act as a base. 
Although arginine is not typically associated with acid-base chemistry in enzymes given its high 
solution pKa, there are reports of arginine residues acting as bases in the literature (35-44). 
Arg301 is not conserved amongst the DHDH family and hence it was not investigated in 
previous studies, but it is conserved in putative PTDH proteins. Given its potentially important 
role in the PTDH reaction, the role of the Arg301 residue in catalysis was extensively tested (see 
Chapter 2).  
In the following chapters of this thesis, further insights into PTDH catalysis will be 
discussed. Chapter 2 presents the discovery of newly-identified PTDHs from other organisms 
and the investigations of the role of Arg301. Chapter 3 will discuss the catalytic role of Met53, 
another active site residue that is conserved in PTDHs. The function of Met53 was studied 
collaboratively by computational and experimental methods. Chapter 4 will address efforts to 
mutate PTDH to accept thiophosphite as an alternate substrate through directed evolution. 
Finally, Appendix A will discuss the possibility that the PTDH reaction progresses through a 
covalent catalysis mechanism.  
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CHAPTER 2: IDENTIFICATION AND CHARACTERIZATION OF THE 
CATALYTIC RESIDUE ARG301 IN PTDH 
 
2.1 Introduction 
The recently published crystal structure of the ternary complex for the thermostable 
phosphite dehydrogenase variant from Pseudomonas stutzeri WM88 (TS-PTDH, PDB: 4E5K) 
(1), has allowed for preliminary identification of the residues in the PTDH active site pocket that 
may be catalytically important. Several conserved residues that were previously studied based on 
the homology of PTDH to the greater family of NAD+-dependent D-hydroxyacid 
dehydrogenases (DHDHs) (2) are indeed present in the active site. These include the previously 
investigated His292, Glu266, and Arg237 residues (3), which are highly conserved and thought 
to play important roles in DHDH catalysis (4-6). The hypothesized roles of these residues in 
PTDH were discussed in detail in Chapter 1.  
In addition to these previously characterized residues, the crystal structure uncovered 
additional active site residues that are not conserved in the DHDH family and that had not been 
investigated thus far (Figure 2.1). As discussed herein, more PTDHs have recently been 
identified (7-10), and it appears that the PTDHs are a distinct subfamily of the greater DHDH  
 
This chapter contains material adapted with permission from:  
Hung, J. E., Fogle, E. J., Christman, H. D., Johannes, T. W., Zhao, H. M., Metcalf, W. W., and van 
der Donk, W. A. (2012) Investigation of the Role of Arg301 Identified in the X-ray Structure of 
Phosphite Dehydrogenase, Biochemistry 51, 4254-4262. Copyright 2012 American Chemical Society.  
And adapted from:  
Hung, J.E., Fogle, E. J., Garg, N., Chekan, J. R., Nair, S. K., and van der Donk, W. A. Chemical 
Rescue and Inhibition Studies to Determine the Role of Arg301 in Phosphite Dehydrogenase, 
Submitted.  
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profiles, isotope effects, X-ray crystallography, chemical rescue experiments, and inhibition 
experiments are reported.  
 
2.2 Results and Discussion 
2.2.1 Identification and Characterization of PTDH Orthologs 
 Several uncharacterized proteins from different bacteria were selected to test for PTDH 
activity based on the level of their sequence identity (44-56%) to wild type (wt) PTDH from P. 
stutzeri in a BLAST survey (Table 2.1). 
 
Table 2.1. Pairwise sequence identities of PTDH orthologs with confirmed activity.  
 
R. 
metallidurans 
Nostoc sp. 
7120 P. stutzeri 
N. 
punctiforme A. faecalis 
M. 
extorquens 
R. metallidurans 100%      
Nostoc sp. 7120 39.4% 100%     
P. stutzeri 43.7% 52.7% 100%    
N. punctiforme 38.8% 71.5% 52.4% 100%   
A. faecalis 41.9% 56.3% 51.4% 56.4% 100%  
M. extorquens 50.2% 49.4% 55.6% 50.2% 49.2% 100% 
 
These proteins were heterologously expressed in E. coli, purified, and assayed for PTDH 
activity with phosphite and NAD+ (Table 2.2). The enzymes from Nostoc sp. 7120, 
Pseudomonas stutzeri, Nostoc punctiforme, and Ralstonia metallidurans were characterized by 
Harry Christman in the Metcalf group (7). Characterization of the PTDH from Alcaligenes 
faecalis was reported previously (22). The enzyme from Methylobacterium extorquens was 
characterized in my work. NADH formation was observed spectrophotometrically and phosphate 
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production was verified by malachite green assay (23). Each of the proteins tested were found to 
catalyze the same chemical reaction as the PTDH from P. stutzeri.  
 
Table 2.2. Kinetic characterization of PTDH orthologs at 30 °C. PT refers to phosphite. Error 
bars in parentheses were obtained from fits to the Michaelis-Menten equation. Enzyme from M. 
extorquens contained an N-terminal His6-tag whereas the other enzymes did not. Reprinted with 
permission from (7). 
 P .  s t u t z e r i  R.. metallidurans Nostoc sp. 7120 N. punctiforme M. extorquens 
Km,NAD (µM) 52.2 (3.3) 4.5 (0.9) 10.3 (1.4) 19.4 (1.6) 40.5 (11.1) 
Km,PT (µM) 81.1 (1.6) 54.9 (6.8) 20.2 (1.6) 25.4 (1.2) 237 (36) 
kcat (s-1) 6.57 (0.03) 6.83 (0.43) 2.41 (0.03) 3.36 (0.03) 5.10 (0.14) 
 
The increase in available PTDH protein sequences suggests that a substantial branch of the 
DHDH family is likely composed of phosphite dehydrogenases (Figure 2.3, Table 2.3). Four of 
these enzymes were found to catalyze phosphite oxidation to complement the previously 
characterized enzymes from P. stutzeri (2) and A. faecalis (22). In addition, recent reports in the 
literature have documented several other microorganisms that also encode proteins that exhibit 
PTDH activity (8-10). Analysis of the kinetic parameters of these enzymes illustrates that they 
all have similar kcat values despite a high degree of sequence diversity (39-72% pairwise identity, 
Table 2.1). The similar kinetic parameters and the fact that the enzymes catalyze the same 
chemical reaction suggest that the PTDH orthologs utilize the same mechanism as the PTDH 
from P. stutzeri.  
20 
 
 
Figure 2.3. PHYLIP unrooted tree for PTDH orthologs and various DHDHs. Abbreviations used are 
explained in Table 2.3.  
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Table 2.3. Designations for PTDH orthologs and various DHDHs. DGDH, D-
glycerate dehydrogenase; DPGDH, D-3-phosphoglycerate dehydrogenase; DLDH, 
D-lactate dehydrogenase. 
Label Strain Accession Number 
PTDH 1 Pseudomonas stutzeri WM88 AAC71709 
PTDH 2 Nostoc punctiforme PCC 73102 YP_001866684.1 
PTDH 3 Nostoc sp. 7120 NP_478512 
PTDH 4 Alcaligenes faecalis AAT12779.1 
PTDH 5 Methylobacterium extorquens AM1  ACS43224 
PTDH 6 Ralstonia metallidurans CH34 YP_585134.1 
DLDH 1 Lactobacillus helveticus P30901 
DLDH 2 Corynebacterium glutamicum ATCC 13032 YP_225194 
DLDH 3 Aquifex aeolicus VF5 NP_213499 
DLDH 4 Saccharomyces cervisiae S288c NM_001180234 
DLDH 5 E. coli K-12 NP_415898 
DLDH 6 Staphylococcus aureus subsp. aureus COL YP_187328 
DGDH 1 Hyphomicrobium methylovorum P36234 
DGDH 2 Methylobacterium extorquens AM1  Q59516 
DGDH 3 Coleus blu Q65CJ7 
DGDH 4 Rhizobium etli AC035311 
DGDH 5 Homo sapiens NP_036335 
DGDH 6 Thermococcus litoralis BAB40320 
DPGDH 1 E. coli P08328 
DPGDH 2 Homo sapiens NM_006623 
DPGDH 3 Mus musculus NM_016966 
DPGDH 4 Aphanothece halophytica BAF91727 
DPGDH 5 Mycobacterium tuberculosis H37Rv NP_215242 
DPGDH 6 Arabidopsis thaliana NP_001031061 
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The residues Arg237, Glu266, and His292 are highly conserved among the DHDH family 
and have been shown to be important for catalysis in PTDH (3, 11). With more than one PTDH 
now identified experimentally, a sequence alignment was performed to determine if any other 
residues are conserved among this enzyme family. Based on this alignment, Arg301, Ser295, 
Tyr139 and Trp134 were found to be fully conserved among PTDHs but not among the DHDH 
family (Figure 2.4). Furthermore, all four residues are near the phosphite binding site (Figure 
2.1) in the X-ray structure. Several other conserved residues were observed, but in the crystal 
structure of PTDH these residues are distant from the enzyme active site (1). Another conserved 
residue that is present in the active site, Met53, is discussed in Chapter 3. 
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Figure 2.4. Partial sequence alignment of several previously-investigated D-hydroxy acid 
dehydrogenases with enzymes with confirmed PTDH activity (7, 22). Numbering is based on PTDH from 
P. stutzeri WM88. Residues within the active site that may be important for catalysis are denoted by an 
asterisk. Highlighted in red are residues that are completely conserved among both DHDHs and PTDHs. 
Highlighted in yellow are residues that are completely conserved only among PTDHs. The important 
catalytic residues Arg237, Glu266 and His292 are conserved among both groups (5, 24, 25). Residues 
Ser295, Tyr139, Trp134, Arg301, identified at or near the active site in the crystal structure (1), are only 
conserved among PTDHs. Lys76 was previously believed to be important for binding phosphite but the 
X-ray structure shows instead it interacts with the pyrophosphate of NAD+ (1). Abbreviations (% identity 
with wt-PTDH, accession number): Nostoc punctiforme PCC 73102 (54%, YP_001866684.1); Nostoc sp. 
7120 (54%, NP_478512); Alcaligenes faecalis (53%, AAT12779.1); Methylobacterium extorquens AM1 
(56%, ACS43224); Ralstonia metallidurans CH34 (47%, YP_585134.1); DGDH, D-glycerate 
dehydrogenase (Hyphomicrobium methylovorum, 27%, P36234) (26); DPGDH, D-3-phosphoglycerate 
dehydrogenase (E. coli, 24%, P08328) (27); and DLDH, D-lactate dehydrogenase (Lactobacillus 
helveticus, 26%, P30901) (28).  
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2.2.2 Steady State Assays of PTDH Active Site Mutants 
To investigate the importance of Arg301, Ser295, Tyr139, and Trp134 for catalysis, site-
directed mutagenesis was performed to generate the following mutants, all in the 17X-PTDH 
background: Arg301Lys, Arg301Ala, Ser295Ala, Tyr139Phe, Trp134Phe, and Trp134Ala. All 
mutants were successfully expressed in E. coli as N-terminal His6-tagged fusion proteins and 
purified by immobilized Ni2+ affinity chromatography.  
Steady state kinetic assays were used to determine the effect of each mutation on enzyme 
activity (Table 2.4). Overall, the values of kcat for all mutants except Arg301Ala are very similar 
to the parent PTDH. The kcat of the R301A mutant was reduced about 100-fold, but the kcat of the 
R301K mutant was actually slightly increased compared to 17X-PTDH. Km,Phosphite was greatly 
increased for both Arg301 mutants, with a particularly large increase (almost 700-fold) for 
R301A.   Km,NAD was also increased 10-fold for the R301A mutant with a more modest increase 
(3-fold) for R301K. Use of a full matrix of varying phosphite and NAD+ concentrations allowed 
determination of the dissociation constant for NAD, Kia,NAD, using the equation (see Materials 
and Methods) (29) for an ordered, sequential mechanism in which NAD+ binds prior to 
phosphite (2) (Figure 2.5). Mutations of Arg301 did not substantially increase Kia,NAD (Table 
2.4), perhaps not unexpected given the large distance between Arg301 and the cofactor in the 
crystal structure (1). In the X-ray structure, Arg301 participates in the dimer interface for 17X-
PTDH (Figure 2.1). To ensure that the data obtained with the Arg301Ala mutant were not a 
consequence of disruption of the oligomerization state of the protein, gel filtration experiments 
were performed, which showed that the Arg301Ala mutant remains a dimer.  
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Table 2.4.  Steady State Parameters of 17X-PTDH Mutants.a 
 
kcat 
(s-1) 
Km, PT 
(mM) 
Km, NAD 
(mM) 
Kia, NAD 
(mM) 
kcat/Km, PT 
(M-1s-1) 
Dkcat D(kcat/Km,PT) 
17X-
PTDHb 
3.27 
(0.24) 
0.028 
(0.007) 
0.022 
(0.006) 
1.0 
(0.3) 
1.2 (0.3) x 
105 
2.3 
(0.1) 
2.1  
(0.2) 
R301Kb 4.50 (0.72) 
1.1 
(0.1) 
0.074 
(0.007) 
0.97 
(0.14) 4,000 (800)
1.9 
(0.1) 
2.2  
(0.5) 
R301Ab 0.041 (0.007) 
19 
(1) 
0.22 
(0.02) 
0.48 
(0.07) 2.1 (0.4) 
2.7 
(0.1) 
2.1 
(0.2) 
S295Ac 2.53 (0.22) 
0.10 
(0.02) 
0.25 
(0.03)  nd
d 2.5 (0.5) x 104 Nd
 Nd 
W134Fc 2.96 (0.10) 
0.24 
(0.01) 
0.10 
(0.01) nd 
1.2 (0.1) x 
104 
2.2 
(0.1) 
2.7  
(0.2) 
W134Ac 1.73 (0.14) 
1.9  
(0.1) 
0.19 
(0.02) nd 900 (90) 
2.2 
(0.1) 
2.1  
(0.2) 
Y139Fc 3.68 (0.37) 
0.039 
(0.002) 
0.036 
(0.002) nd 
9.4 (1.1) x 
104 nd nd 
a All assays were performed at 25 °C, pH 7.25 in 100 mM MOPS. PT refers to phosphite. kcat 
values were obtained for three batches of each enzyme and the average is presented here (see 
Materials and Methods). b The values were determined by varying the concentrations of both 
substrates, determining the initial rates, and fitting all data to the equation shown in the Materials 
and Methods section. c The values were determined by holding one substrate at saturating 
concentration and varying the concentration of the other substrate. Initial rates were fit to the 
Michaelis Menten equation. The errors given in parentheses are obtained from the fits of the 
experimental data to the respective equations (see Materials and Methods). d nd—not 
determined. Reprinted with permission from (7). 
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Figure 2.5. Steady-state kinetic assays of 17X-PTDH and Arg301 mutants fit simultaneously to 
the appropriate equation for a two-substrate reaction with NAD+ binding first and phosphite 
binding second (30). (A) 17X-PTDH (B) R301K, and (C) R301A. Pt stands for phosphite, uM 
stands for µM, Ka stands for the Km,NAD, Kb stands for Km,Phosphite, and Ka’ stands for Kia,NAD 
(which is Kd,NAD). 
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The Ser295Ala, Trp134Phe, Trp134Ala, and Tyr139Phe mutants had only slightly reduced 
kcat values compared to 17X-PTDH. As these conservative mutations removed the functional 
groups on the side chains of the residues, the mutagenesis studies suggest that these residues do 
not play an important role in catalysis. Mutations of Trp134 did affect the Km values for 
phosphite, with the Trp134Ala mutant exhibiting a 40-fold increase in Km,Phosphite. The 
Trp134Phe mutant had a similar effect on Km,Phosphite, although it was smaller in magnitude. It is 
likely that the residues play roles in optimizing catalytic efficiency, perhaps by helping position 
Arg301 to which they are hydrogen bonded in the wt enzyme (1).  Kinetic isotope effect (KIE) 
experiments performed with selected mutants yielded normal Dkcat and Dkcat/Km,Phosphite values, 
which were similar in magnitude to those observed with 17X-PTDH. These results suggests that 
hydride transfer remains rate-limiting at pH 7.25, as has been previously shown for wild-type 
PTDH and a series of mutants with a wide range of catalytic activities (31).  
Arg301 is fully conserved among all confirmed PTDH enzymes, and in the crystal structure 
it is located with its side chain pointed towards sulfite in the active site, with a total distance of 
7.0 Å between the terminal nitrogen of the guanidine and sulfur atom. Given the results of the 
mutagenesis studies, it is clear that Arg301 plays an important role in PTDH catalysis, though its 
exact role is unclear from the steady state kinetics data. The magnitude of the reduction in kcat of 
the Arg301Ala mutant and the observation that the Arg301Lys mutant retained a comparable kcat 
to 17X-PTDH are similar to the findings with mutants of inosine monophosphate dehydrogenase 
for which a role of an Arg as active site base to deprotonate a water molecule has been proposed 
(12-14, 32, 33). Indeed, a water molecule is present between the Arg301 side chain and sulfite, 
and it is in good orientation and distance to act as a nucleophile onto the substrate. Arginine is 
not commonly considered in the acid-base chemistry of proteins owing to its relatively high 
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solution phase pKa, but several recent reports have documented enzymes in which arginine have 
been proposed to act as a base (12-21). However, the observed phenotype of the Arg301Ala 
mutant may also be attributed to removal of an important electrostatic effect (i.e. if Arg301 is 
positively charged as expected based on its pKa). To further characterize the catalytic role of 
Arg301, pH dependence experiments were performed.  
 
2.2.3 pH Rate Profiles of 17X-PTDH Mutants 
The pH dependence of the steady-state kinetic constants was determined for 17X-PTDH-
R301A and 17X-PTDH-R301K, the mutants with the most interesting phenotypes. Like wt-
PTDH (11), the pH rate profile for 17X-PTDH is pH independent for log(kcat) (Figure 2.6A) and 
displays a bell-shaped curve for log(kcat/Km,Phosphite) (Figure 2.6B) with extracted pKa values of 
6.53 ± 0.10 and 7.90 ± 0.08 from a fit to the appropriate equation (see Materials and Methods).  
The pH rate profile for R301K was overall similar to that of 17X-PTDH. The log(kcat) profile is 
pH independent in the range of pH 7-9, but it appears that a deprotonation event with a pKa of 
5.93 ± 0.03 may affect kcat. This pKa is close to the limits of the pH range in which this mutant is 
stable (Figure 2.6C), and the data cannot completely rule out that the observed decrease in 
activity may be the result of loss of activity that is not associated with a defined ionizable 
residue. The mutant displays a bell shaped curve for log(kcat/Km,Phosphite), with extracted pKa 
values of 6.62 ± 0.05 and 8.37 ± 0.07 for the two proton transitions (Figure 2.6D).  
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Figure 2.6. pH rate profiles of log(kcat) and log(kcat/Km,Phosphite) for 17X-PTDH (panels A and B, 
respectively), 17X-PTDH-R301K (panels C and D), and 17X-PTDH-R301A (panels E and F). 
When error bars are not visible, they were smaller than the font size used for the data point. 
Reprinted with permission from (7). 
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In contrast to the plots for kcat/Km,Phosphite and kcat of 17X-PTDH and R301K, the pH 
dependence of the kinetic parameters of R301A was very different. The plot of log(kcat) versus 
pH was nearly linear with a slope of 0.6 (Figure 2.6E) and may suggest specific base catalysis by 
hydroxide. Slopes less than 1 have been reported previously (34-37) and a number of reasons can 
be offered including a decreased activity coefficient of hydroxide in the active site environment, 
a partial contribution of an uncatalyzed reaction (i.e. with water as nucleophile), or the 
superposition of titration curves of multiple different ionizable residues with a hydroxide ion 
dependent specific base mechanism.  In contrast, log(kcat/Km,Phosphite) was essentially pH 
independent (Figure 2.6F). This latter finding is the result of offsetting effects on kcat and 
Km,Phosphite (Table 2.6). The former increases with pH resulting in improved catalysis, but the 
latter also increases with pH, resulting in less efficient catalysis at low substrate concentrations. 
The same findings were obtained in three different buffer systems: a universal buffer of constant 
ionic strength (38), a broad-range Tris-maleate buffer, and MOPS, the standard PTDH assay 
buffer (Table 2.5). The data in Figure 2.5 were obtained in the universal buffer. 
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Table 2.5. Steady-state kinetic constants for 17X-PTDH and the R301A mutant in different 
buffers at pH 7.25. Assays were performed at optimal pH of 7.25, 25 °C in different buffers. 
NAD+ concentrations were held at saturating values. PT refers to phosphite. High Km values in 
‘Universal’ buffer increased the error. nd = not determined. Errors given in parenthesis are 
determined from the fit to the Michaelis-Menten equation. 
 Buffer kcat (s-1) Km,PT (mM) kcat/Km,PT (M-1s-1) Dkcat Dkcat/Km,PT 
17X-
PTDH MOPS 
3.26 
(0.15) 
0.050 
(0.005) 5.9 (0.6) x 10
4 2.16 (0.15) 1.78 (0.2) 
R301A MOPS 0.038 (0.001) 
28         
(1) 1.4 (0.1) 
2.67 
(0.09) 2.06 (0.22) 
17X-
PTDH Universal 
2.71 
(0.09) 
0.090    
(0.01) 3.0 (0.1) x 10
5 nd nd 
R301A Universal 0.038 (0.001) 
650        
(45) 0.059 (0.004) 
4.32 
(0.30) 2.35 (0.44) 
17X-
PTDH Tris maleate 
2.93 
(0.04) 
0.37   
(0.02) 8.0 (0.4) x 10
3 2.01 
(0.05) 2.05 (0.19) 
R301A Tris maleate 0.039 (0.001) 
49         
(3) 0.79 (0.21) 
2.20 
(0.1) 2.71 (0.79) 
 
If Arg301 indeed is the active site base, the observation that its pKa is not seen in the pH-rate 
plots for 17X-PTDH (Figure 2.6) can have several explanations. One is that the rate constant for 
water deprotonation is not in the rate equation (i.e. it takes place after the rate determining step, 
which for 17X-PTDH is hydride transfer based on KIEs and pre-steady kinetic state 
measurements). Such a model would imply a dissociative reaction in which hydride transfer 
occurs prior to attack by the nucleophile. Alternatively, the nucleophile could be water and 
deprotonation could occur after hydride transfer. There is no evidence for either scenario and 
both models appear unlikely, but there is also no direct evidence against these possibilities. 
Another possible scenario in which Arg301 would not show up in the pH-rate plots for 17X-
PTDH is that its pKa is above 9 and outside the pH range we experimentally investigated. If so, 
then only a very small fraction of the enzyme would contain a deprotonated Arg that could 
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accept the proton from water. But, as pointed out previously for other biological catalysts (13, 
39, 40), this would not preclude catalysis. Again, at present we have no evidence that this is the 
case for PTDH.  
For log(kcat/Km,Phosphite) of the R301A mutant, both the basic and acidic limbs of the pH rate 
profile disappeared, yielding a pH-independent profile. As the pKa of phosphite (corresponding 
to the acidic limb of the profile) should not have been altered by the mutation of Arg301, these 
results argue that either the acidic limb observed with wt-PTDH is not associated with substrate, 
or more likely that a change in mechanism has occurred for the mutant. To address this 
possibility, the KIEs for the R301A mutant were determined over the pH range. 17X-PTDH 
displays KIEs that do not change significantly over the pH range. In contrast, substrate deuterium 
KIEs obtained at three pH values in Tris-maleate buffer for R301A showed that Dkcat increased as 
the pH was raised (Table 2.6). This result is consistent with a change in mechanism over the pH 
range, with the chemical step of the reaction becoming more rate limiting in a basic environment. 
The pH dependence of D(kcat/Km,Phosphite) of 17X-PTDH-R301A was also very different from that 
of the parent enzyme, displaying a substantially larger value at low pH than at high pH, 
indicating that commitment to catalysis is much smaller at low pH. This stronger selection 
against deuterium labeled phosphite could be a consequence of a slower chemical step or an 
increase in the dissociation rate of the substrate. As the maximum KIE for a P–H/P–D bond is 
calculated to be approximately 5.0 (41), it is also possible that the KIEs for the mutant are 
approaching the intrinsic KIE at the pH extremes. The observed changes in the kinetic 
mechanism as a function of pH could have many causes (e.g. different chemical mechanism, 
different relative rate constants, different order of addition, etc.) that were not further 
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investigated, as such studies on a mutant with very different properties than wt-PTDH would not 
provide much insight into the physiological reaction.  
 
Table 2.6.  KIEs of 17X-PTDH-R301A at different pH values. All assays were performed at 
25 °C in 100 mM Tris maleate buffer of varying pH. PT refers to phosphite. Errors, given in 
parentheses, are from fits of the data to the Michaelis Menten equation. Similar changes in the 
KIEs as the pH was varied were also observed in MOPS and the Universal buffer.   
 kcat (s-1) Km, PT (mM) kcat/Km (M-1s-1) 
D(kcat) D(kcat/Km)
pH 5.5 0.005 (0.001) 5.2 (1.0) 0.90 (0.18) 1.3 (0.1) 7.4 (1.6) 
pH 7.3 0.039 (0.001) 49 (3) 0.79 (0.21) 2.2 (0.1) 2.7 (0.8) 
pH 8.3 0.25 (0.02) 920 (190) 0.28 (0.06) 6.0 (0.6) 2.1 (0.6) 
 
Overall, the large changes in the Km values for both substrates as well as the drastically 
different pH dependence of both kcat and kcat/Km,Phosphite suggest that the R301A mutant is 
severely disrupted and that its mechanism of catalysis may not be representative for the parent 
enzyme. Therefore, the pH dependence data of R301A do not directly support Arg301 acting as a 
base in catalysis.  
An electrostatic role of Arg301 appears to be supported by the data obtained for 17X-PTDH-
R301K. This mutant shows a more modest increase in Km,Phosphite and has a slightly improved kcat 
compared to 17X-PTDH. Furthermore, the pH-rate profiles are very similar with the only 
substantial change being a shift of the basic pKa in the bell shaped curve for log(kcat/Km,Phosphite) to 
a higher value (from 7.9 to 8.4). If this pKa indeed represents His292 (11, 42), its pKa could be 
raised because of a weaker electrostatic destabilization of the imidazolium group of His292 by a 
protonated Lys than by a protonated Arg. Collectively, the steady state kinetic parameters and 
the pH rate profiles suggest that lysine is capable of playing a similar catalytic role as arginine, 
and these observations are more readily explained by an electrostatic interaction than by a role as 
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base. These positively charged residues may also be important for orienting the phosphite 
substrate for efficient catalysis.  
 
2.2.4 X-Ray Crystallography of Arg301Ala and Arg301Lys Mutants of 17X-PTDH 
Crystals were obtained that contained NAD+ and that diffracted to 2.35 Å and 2.65 Å for the 
R301A and R301K (Figure 2.7A) mutants, respectively. The R301A crystal was grown by Neha 
Garg whereas I grew the R301K crystal. The crystals were diffracted and the structures solved by 
Jonathan Chekan and Professor Satish Nair as reported in (43). Superposition of the mutant 
structures with the crystal structure of the parent 17X-PTDH containing NAD+ (1) revealed that 
the overall structure of the mutants was unchanged, with the exception of the appearance of a 
solvent-accessible channel into the substrate binding pocket caused by the mutation of Arg301 
(Figure 2.7B). This effect is more pronounced for R301A than R301K. Unfortunately, the side 
chain of Lys301 exhibits poor electron density in the latter mutant indicating that the Lys does 
not occupy a well-defined position in the crystal. Attempts to co-crystallize the PTDH mutants 
with sulfite inhibitor did not yield crystals containing sulfite nor did attempts to soak the ligand 
into the crystals generate structures that contained sulfite. 
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aminoguanidine, ethylguanidine, or N-guanylurea (Table 2.7). Rescue was not observed with 
nitroguanidine, hydroxyurea, urea, thiourea, imidazole or with primary amines such as 
methylamine, ethylamine, and butylamine (all tested at concentrations of 20 – 100 mM 
depending on aqueous solubility limits). The failure for reagents other than guanidine derivatives 
to rescue mutations of Arg residues has been observed previously for other enzymes (32, 45). 
For each successful reagent, the kcat,apparent (the maximal activity at each concentration of rescue 
reagent under saturating concentrations of both substrates) of the reaction increased in a 
hyperbolic fashion as the concentration of rescue reagent was increased (Figure 2.8). At 
saturating substrate concentrations, the addition of a saturating concentration of rescue agent led 
to a 10- to 30-fold increase in krescue (kcat,apparent under conditions of saturating rescue reagent) 
compared to kcat for the R301A mutant without any rescue reagent, yielding about 40% of wild-
type activity with the most effective reagent, aminoguanidine (Table 2.7). Whereas kcat could be 
restored, the high Km,Phosphite observed with the R301A mutant was not significantly decreased 
towards wild type values in the presence of saturating rescue reagent. The activity of the parent 
17X-PTDH was unaffected at the highest concentrations of rescue reagent used, suggesting that 
the absence of the Arg301 side chain in the mutant is necessary for the small molecules to affect 
activity. The stability of the engineered 17X-PTDH towards guanidinium derivatives may be 
related to its engineered increased thermostability compared to wt PTDH. The observed 
saturation kinetics with respect to rescue agent for the R301A mutant combined with the 
unperturbed kinetics of the parent 17X-PTDH in the presence of rescue agent strongly suggest 
that the observed improvement in catalysis by R301A imparted by the rescue reagents involves a 
quaternary complex (enzyme, NAD+, phosphite, and rescue agent).  
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Table 2.7.  Steady State Constants for Chemical Rescue of Activity on R301A  
 krescue (s-1) 
Km, 
phosphite 
(mM) 
krescue / 
Km, 
phosphite 
(M-1s-1) 
KR 
(mM) )
/log( rescue
Base
RK
k
 
pKa a Dkcat Dkcat/Km 
R301A + 
guanidine 
1.23 
(0.05) 
30     
(3) 
41      
(4) 
17.9 
(2.9) 
8.13 
(0.07) 13.6
 1.79 
(0.07) 
2.3 
(0.1) 
R301A + 
methylguanidine 
0.68 
(0.04) 
130 
(30) 
5.2  
(1.1) 
54.5 
(9.5) 
7.20 
(0.08) 13.4 
1.35 
(0.14) 
1.6 
(0.5) 
R301A + 
acetamidine 
0.86 
(0.08) 
130 
(20) 
6.7  
(1.1) 
63.0 
(14.9) 
6.33 
(0.11) 12.5 
1.50 
(0.13) 
1.8 
(0.6) 
R301A + 
aminoguanidine 
1.35 
(0.04) 
7.4 
(0.5) 
180  
(13) 
31.5 
(1.7) 
5.33 
(0.03) 11.0 
2.10 
(0.05) 
3.1 
(0.3) 
R301A + 
ethylguanidine 
0.52 
(0.13) nd nd 
439 
(194) 
6.09 
(0.22) 13.3 nd nd 
R301A + N-
guanylurea 
0.42 
(0.07) nd nd 
116 
(36.3) 
-2.85 
(0.15) 3.9 nd nd 
The errors given in parentheses were obtained from fits of the experimental data to the 
appropriate equations. na = not applicable. nd = not determined. aData from reference (46).  
 
Although the R301K mutant possesses slightly higher activity than the parent enzyme, amine 
bases failed to affect the activity of the R301A mutant. It is possible that the amines tested could 
not attain the correct orientation in the active site cleft introduced by the mutation of Arg301 as 
reported for other examples of unsuccessful rescue of an Arg mutation by alkylamines (47).  
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Figure 2.8. Chemical rescue plots of 17X-PTDH-R301A with (A) guanidine, (B) 
methylguanidine, (C) acetamidine, (D) aminoguanidine, (E) ethylguanidine, and (F) N-
guanylurea. The values of kcat,apparent at each concentration of rescue reagent were determined by 
varying the concentration of phosphite and keeping the concentration of NAD+  fixed at 4 mM 
(saturated). 
 
The KR value, which represents the concentration of rescue reagent that gives half maximal 
rate enhancement, was adjusted to the concentration of rescue reagent in the deprotonated state at 
the assay pH, ܭ୆ୖୟୱୣ, and a linear correlation was observed between the efficiency of R301A 
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rescue and the pKa of the conjugate acid of the rescue reagent (Figure 2.9A). When fit to 
equation 2.5 (see Materials and Methods) by linear regression, a value of the Brønsted parameter 
β of 1.03 ± 0.09 was obtained. The β value near one suggests that transfer of a proton to the 
guanidine group is complete in the transition state of the rate determining step. When the 
apparent outlier point was removed (ethylguanidine, pKa =13.3), a slightly better linear 
correlation is observed, but the Brønsted parameter does not change significantly (β = 1.05 ± 
0.09) (Figure 2.9B). Because correlation between the Taft steric parameters (48) of the rescue 
reagents and rescue activity was poor, the steric contribution was ignored.  
Two scenarios can account for the observed β value. First, the deprotonated rescue reagent 
may act as a general base with complete proton transfer in the transition state of the rate 
determining step. Alternatively, a pre-equilibrium protonation step prior to the rate limiting step 
may take place, and the resulting protonated, positively-charged group is important for the rate 
limiting step. The definition of the Brønsted coefficient allows for both interpretations (49), 
making it difficult to differentiate directly from the rescue data (50). 
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Figure 2.9. Chemical rescue plots for R301A-PTDH. (A) Brønsted plot depicting the observed 
rates of phosphite oxidation by R301A in the presence of various rescue reagents at pH 7.25 as a 
function of their pKa. β = 1.03 ± 0.09 (r2 = 0.96). (B) Chemical rescue plot for R301A-PTDH 
with the data point for ethylguanidine (pKa = 13.3) removed. β = 1.05 ± 0.09 (r2 = 0.97). 
 
2.2.6 Isotope Effect Studies on Chemical Rescue of the Arg301Ala Mutant 
Substrate kinetic isotope effects (KIEs) were determined for the assays with R301A in the 
presence of saturating conditions of rescue agent to determine whether the chemical step 
remained rate limiting. Although some variation was observed in the KIEs of the R301A mutant 
when rescue reagents were added (Table 2.7), moderate KIEs were detected on both Dkcat and 
D(kcat/Km). Hence, chemistry is at least partially rate limited under rescue conditions. Taking into 
account the experimental errors, the KIEs for the rescue experiments are all quite close to those 
observed with 17X-PTDH.  
The KIEs suggest that the chemical step remains rate-limiting, as is the case in the parent 17X-
PTDH (31). We reasoned that if a large β value indeed represented full proton transfer to the 
guanidine group in the transition state of the rate limiting step (i.e. a late transition state with 
respect to proton transfer), that perhaps increasing the barrier for the chemical step by using 
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deuterium labeled phosphite might result in a different value for β (note that the site of labeling 
is not the hydrogen that ends up on the guanidinium group, hence the isotope effect is not on the 
proton transfer step itself). However, a Brønsted plot using deuterium labeled phosphite resulted 
in a β value of 1.05 ± 0.07, which is within error of the value obtained for the protiated reagent. 
Hence, the rather modest change in energy barrier with deuterium-labeled phosphite did not 
appreciably change the timing of the proton transfer event.  
The solvent isotope effect (SIE) on kcat for the wt enzyme is rather small (1.55 ± 0.07) (11). In 
addition, the SIE and substrate KIE are not multiplicative, suggesting that deprotonation of the 
water nucleophile and hydride transfer are not in the same step (11), or that solvent labeling may 
affect more than just the water deprotonation step (i.e. that the observed SIE is only partially due 
to the deprotonation step and hence that the isotope effect on water deprotonation is less than 
1.55). Such a small isotope effect would not be inconsistent with Arg301 acting as the active site 
base because a β value of 1 implies a very late transition state (where there is effectively full 
bond formation between the guanidine nitrogen and the proton), which in turn would be expected 
to have a small KIE. Of course, SIEs are well known to be difficult to interpret because of the 
many properties of the enzyme that are affected in D2O compared to H2O (49). Nevertheless, we 
also determined the SIE on the reaction catalyzed by the R301A mutant. If Arg were the base 
that deprotonates the water nucleophile, its removal might be expected to greatly affect the SIE, 
either because deprotonation would become more important in determining the overall rate 
(larger SIE), or because the reaction might require specific base catalysis (expected inverse SIE). 
The observed value of 1.77, which is close to that observed with the wt enzyme, does not provide 
strong evidence for either. Hence, although not definitive, the SIE studies do not provide 
evidence for a role of Arg301 as an active site base. 
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2.2.7 pH Dependence of Chemical Rescue 
As discussed above, the observed large slope of the Brønsted plot can be indicative of two 
different scenarios. Either a neutral guanidine group is completely protonated in the transition 
state of the rate determining step or the guanidine group needs to already be protonated in a step 
prior to the rate determining step. As has been noted previously (32), in the former case, one 
would expect the rate at low concentrations of rescue agent to be linearly dependent on the 
concentration of the unprotonated rescue reagent, whereas in the latter case, one would expect 
the overall rate to be dependent on the concentration of protonated rescue reagent. Thus, in 
favorable cases, one can distinguish between these two scenarios by determining the pH 
dependence of the chemical rescue rates in a pH window where the concentration of the 
unprotonated reagent varies strongly with pH but the concentration of the protonated reagent 
does not. For instance, when raising the pH from 7 to 8, the concentration of protonated 
aminoguanidine (pKa = 11.0) does not change substantially, whereas the concentration of neutral 
aminoguanidine increases approximately 10-fold (Table 2.8). Hence, if neutral aminoguanidine 
were the reagent that is responsible for rescue, the observed rate under conditions where 
phosphite and NAD+ are saturating should be directly linear with the concentration of neutral 
aminoguanidine at low concentrations, and should increase roughly 10-fold in going from pH 7 
to 8 (and 3.2-fold going from pH 7.0 to 7.5, Table 2.8). In contrast, if protonated aminoguanidine 
were the active rescue reagent, then the observed rate under these same conditions should be 
nearly the same at pH 7 and 8.  For PTDH, a complication is that at low concentrations of rescue 
agent, background catalysis by R301A is significant, and hence its pH dependence, discussed in 
section 2.2.3, must also be corrected for using equation 2.4 (see Materials and Methods). 
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Another complication is that the Km of phosphite for R301A is strongly pH dependent (Table 
2.6). Indeed, we found that at pH 8.0 the Km value was 300 ± 35 mM, and hence very high (i.e. 
molar) phosphite concentrations were needed to saturate the enzyme. In the presence of rescue 
agent, the Km for phosphite decreases somewhat, but in the low millimolar range of rescue 
reagent, where kcat,apparent would be linear with the concentration of rescue agent, the Km,Phosphite 
was still larger than 150 mM. Hence all experiments were performed with 1 M phosphite. 
 
Table 2.8. Expected proportion of aminoguanidine (pKa = 11.0) in 
unprotonated and protonated states at pH 7.0, pH 7.5, and pH 8.0.  
 Unprotonated (RNH2) Protonated (RNH3+) 
pH 7.0 0.01% 99.99% 
pH 7.5 0.03% 99.97% 
pH 8.0 0.10% 99.90% 
Ratio of concentrations of 
reagent (pH 7.5 : pH 7) 
3.2 1.0 
Ratio of concentrations of 
reagent (pH 8 : pH 7) 
10 1.0 
 
The chemical rescue experiments were performed at pH 7.0, 7.5, and 8.0 with aminoguanidine 
as the most efficient rescue agent. Over the pH range, the krescue value remained mostly 
unchanged, though a slight decrease in KR was observed as the pH increased. At pH 7.0, krescue = 
1.17 ± 0.05 s-1 and KR = 64.5 ± 8.81 mM, at pH 7.5, krescue = 0.91 ± 0.07 s-1 and KR = 22.7 ± 6.2 
mM, and at pH 8.0, krescue = 1.12 ± 0.06 s-1 and KR = 9.9 ± 2.3 mM.  At low concentrations of 
rescue reagent (i.e. KR >> [rescue agent]), equation 2.4 (Materials and Methods) simplifies and 
kcat,apparent corresponds to (krescue/KR)[rescue agent] + kcat,R301A. At each pH value, a linear increase 
in kcat,apparent was observed as the concentration of aminoguanidine was increased (Figure 2.10A). 
As expected, after correction of the pH dependence of the background activity by R301A, the 
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lines nearly intersect in the absence of aminoguanidine (Figure 2.10B). The slope of the line at 
pH 8.0 is significantly larger than at pH 7.0 with a ratio of 3.72 ± 0.31, and the ratio of the slopes 
of the lines at pH 7.5 and pH 7.0 is 1.23 ± 0.10. Both of these ratios are, however, significantly 
smaller than those expected if the unprotonated compound were the active rescue agent 
(expected ratios of 10 and 3.2, respectively, see dashed lines of Figure 2.10B). Conversely, they 
are also larger than 1.0 (expected if the protonated aminoguanidine were the active rescue agent). 
The experiment was repeated with a different batch of enzyme and reagents, but these 
experiments resulted in similar ratios of slopes of 3.0 ± 0.1 (pH 8.0: pH 7.0) and 1.6 ± 0.1 (pH 
7.5 : pH 7.0). Similar results were also observed when the pH dependence of chemical rescue 
was performed with guanidine instead of aminoguanidine. Hence, the experimental pH 
dependence of rescue activity was not definitive with respect to the protonation state of 
aminoguanidine that is required for rescue. It may be that the pH dependence of the background 
reaction combined with the strong pH dependence of Km for phosphite are in part responsible for 
the inconclusive outcome of these experiments. 
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Figure 2.10. pH dependence of chemical rescue for R301A-PTDH. Dependence of the rate of 
chemical rescue on the concentration of aminoguanidine at pH 7.0 (black squares), pH 7.5 (red 
circles), and pH 8.0 (blue triangles) (A) prior to correction for the background activity of R301A 
without rescue agent at each pH and (B) corrected for the pH-dependence of kcat,R301A. Also 
shown is the expected activity at pH 7.5 (red dashed line) and pH 8.0 (blue dashed line) based on 
the observed activity at pH 7.0 if the active reagent were the unprotonated aminoguanidine. 
Experiments were performed in duplicate; when error bars are not visible, the error was smaller 
than the marker. 
 
2.2.8 Sulfite Inhibition Experiments 
Km values of substrates can greatly deviate from their corresponding Kd values because the 
Km term typically contains many more microscopic rate constants than the Kd term. On the other 
hand, the inhibition constants of competitive inhibitors (Kis) can provide a direct reflection of the 
influence of mutations on binding events. Inhibition experiments were therefore performed with 
R301A to determine the Kis value for sulfite (Table 2.9). Similarly to the large increases in 
Km,Phosphite that were observed for the mutant compared to the parent 17X-PTDH (Table 2.4), the 
Kis value also greatly increased. A Kis of 0.31 ± 0.05 µM was observed for 17X-PTDH (Figure 
2.11) whereas the Kis increased to 132.6 ± 19.3 µM for R301A, corresponding to a more than 
400-fold increase. This effect is comparable in magnitude with the nearly 700-fold increase in 
Km,Phosphite. When saturating concentrations of aminoguanidine rescue reagent were added to the 
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reaction with the R301A mutant, the Kis value of 77.8 ± 8.4 µM was only slightly decreased 
compared to the value in the absence of rescue agent. Thus, addition of the rescue reagent fails to 
substantially recover inhibitor binding, just as it is unable to recover Km,phosphite. The Kis for 
R301K was 0.608 ± 0.051 µM, considerably lower than that of R301A-PTDH but still slightly 
increased from 17X-PTDH.  
 
Figure 2.11. Inhibition of PTDH activity by sulfite for (A)17X-PTDH, (B) R301A-PTDH, (C) 
R301A-PTDH + saturating aminoguanidine, and (D) R301K-PTDH. The different symbols 
indicate the concentration of sulfite added.  
 
Overall, the large increase in the dissociation constant for sulfite indicates that Arg301 plays 
a role in inhibitor binding, and likely phosphite binding. This observation is consistent with the 
crystal structure of the R301A mutant, which shows that a cavity into the phosphite binding 
region of the active site is formed (Figure 2.7B). The smaller increase in the inhibition constant 
for sulfite for R301K is consistent with the smaller increase of Km,Phosphite in this mutant, and 
suggests that the Arg301Lys mutation may be able to regain some of the phosphite binding lost 
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in the R301A mutant by blocking the channel into the active site, which is again consistent with 
the placement of the residue in the active site (Figure 2.7A).  
In addition to the sulfite dissociation constants, the Kd for phosphite itself can be calculated 
from D(V/K), DV and Km,Phosphite using the method of Klinman and Matthews (51). The Kd for 
phosphite so determined is 23 ± 6 µM for 17X-PTDH and 12.6 ± 1.5 mM for R301A, again 
showing a large decrease in affinity for the substrate in the mutant. Collectively, these findings 
along with the X-ray structures illustrate that proper positioning of the side chain of Arg301 is 
very important for efficient capturing of phosphite (52), which cannot be recapitulated by the 
rescue agents for the R301A variant. 
 
Table 2.9.  Sulfite inhibition constants 
for Arg301 mutants of 17X-PTDH 
 Kis (µM) 
17X-PTDH 0.31 (0.05) 
R301A 130 (20) 
R301A + 
aminoguanidine 78 (8) 
R301K 0.61 (0.05)  
 
2.3 Conclusions 
The studies presented here indicate that PTDH activity is not unique to the enzyme from P. 
stutzeri, but that the PTDHs are instead a distinct branch of the greater DHDH family. The 
reaction catalyzed by PTDHs has a very strong thermodynamic driving force and it has been 
speculated that perhaps the rather moderate values of kcat were the result of a “young” enzyme 
that had relatively recently evolved from a progenitor in the DHDH family (11).  The strong 
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sequence diversity suggests that instead phosphite oxidation is likely an old activity, and the very 
similar catalytic parameters, combined with the inability to increase kcat substantially by directed 
evolution (53), suggest that the rates of phosphite oxidation by PTDHs may be limited by a 
relatively high intrinsic barrier.  
With the recently determined crystal structure of TS-PTDH (1) and the sequences of additional 
PTDH orthologs with moderate sequence homology to the enzyme from P. stutzeri, several 
previously unidentified conserved residues near the active site have been revealed. These amino 
acids include Ser295, Tyr139, Trp134, and Arg301, which are conserved among the known 
members of the PTDH family but not the greater DHDH family. While mutations to Ser295, 
Tyr139, and Trp134 have minimal effect on kcat of the reaction, the Arg301Ala mutant exhibits ~ 
100-fold reduced kcat and greatly increased Km for phosphite, indicating that it plays an important 
role in the reaction.  
From its position in the crystal structure, Arg301 could be playing a number of roles in 
catalysis. It is in good position and orientation relative to a water molecule in the active site that 
would allow it to act as the catalytic base to deprotonate the water nucleophile that attacks 
phosphite. Alternatively, it could act as a positively charged residue to promote electrostatic 
catalysis. Initial studies to probe the mechanism of catalysis with a pH rate profile of R301A 
proved inconclusive, as KIE experiments showed the mechanism of R301A changes over the pH 
range. However, the pH rate profile of the R301K mutant exhibited a shift in the basic limb of 
the log(kcat/Km,Phosphite), suggesting that Arg301 may act in electrostatic catalysis by destabilizing 
the His292 imidazolium.  
The crystal structure of the R301A mutant exhibits a solvent-exposed phosphite binding site 
that is covered by the side chain of Arg301 in the wild type structure. The appearance of a cleft 
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into the active site prompted the attempt of chemical rescue studies, which showed that 
exogenous guanidinium analogs were able to enhance activity of the R301A mutant. Brønsted 
linear free energy analysis with the rescue reagents yielded a high β value, which could be 
attributed to a high degree of proton transfer to the rescue reagent in the transition state of the 
rate limiting step of the reaction (if Arg301 acts as a base). Alternatively, a pre-equilibrium 
protonation event of Arg301 could occur, which would again result in the group be fully 
protonated at the transition state of the rate-determining step.  
Although the pH dependence of rescue unfortunately did not conclusively resolve whether the 
rescue reagent is in the protonated or unprotonated state, a protonated aminoguanidine as the 
active rescue agent (and hence a protonated Arg side chain in the wild type enzyme) is the most 
straightforward interpretation of all the current data. The essentially complete proton transfer 
indicated by the β value, the very small SIE for the wt enzyme, and the previous finding that the 
SIE and substrate KIE on kcat were not multiplicative for the wt enzyme (11), suggesting that 
deprotonation of the water nucleophile and hydride transfer are not in the same step, are all in 
agreement with a protonation of the guanidine prior to the rate limiting step. In addition, if Arg 
were the base that deprotonates the water nucleophile, its removal might be expected to greatly 
affect the SIE, either because deprotonation would become more important in determining the 
overall rate (larger SIE), or because the reaction might require specific base catalysis (inverse 
SIE expected). The observed SIE of 1.77, which is close to that observed with the wt enzyme, 
does not provide strong evidence for either. Hence, although not definitive, I tentatively conclude 
that Arg301 is protonated during catalysis and is not the active site base.  
The importance of the protonated side chain for catalysis is obvious, given the large decrease 
in kcat upon its removal in R301A, and the fact that addition of exogenous guanidine analogs can 
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recover activity. The purpose of Arg301 in catalysis may be to properly orient phosphite for 
efficient hydride transfer, to activate the water molecule for deprotonation, or to activate the 
phosphite electrophile electrostatically. The pH profiles also indicate that it is possible that 
Arg301 decreases the pKa of the imidazolium group of His292 such that it can serve as the base. 
Inhibition experiments showed that the R301A mutant binds the sulfite inhibitor poorly, which 
correlates with the high Km and Kd for phosphite of the mutant. Addition of rescue reagent was 
unable to improve sulfite binding, indicating that Arg301 is important for the binding of the 
phosphite substrate, and this role may be independent of its electrostatic role in catalysis.  
Overall, these studies suggest that Arg301 is not the catalytic base in the PTDH reaction. It is 
likely that His292 instead plays this role. The orientation of His292 in the enzyme active site is 
consistent with a role as a base (1), and His292 mutations completely abolish activity (3), as does 
covalent modification of the His residues by DEPC (3). Unfortunately, previous attempts to 
rescue activity of mutants of His292 by Dr. Emily Fogle were unsuccessful (43).  
 
2.4 Materials and Methods 
2.4.1 Materials   
All chemicals were obtained from Sigma or Aldrich and used without further purification. The 
development of 17X-PTDH is reported in (54); in the reference this mutant is called 12X-PTDH, 
but it actually contains 17 mutations. In the crystal structure of 17X-PTDH, all mutated residues 
are distant from the active site, with the exception of E175A, which disrupts an interaction with 
the ribose group of NAD+ to allow NADP to be used as a substrate (1).  
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2.4.2 General methods 
The concentration of NAD+ stock solutions were determined by the absorbance at 260 nm (ε = 
18,000 M-1 cm-1). The concentration of stock solutions of phosphite was determined by running 
the PTDH reaction to completion in the presence of excess NAD+. The maximum absorbance at 
340 nm was then measured, which represents the concentration of NADH formed (ε = 6.2 mM-1 
cm-1) and is equivalent to the concentration of phosphite consumed. Tris buffer was made from 
Tris base and adjusted to the correct pH with 5 M HCl; MOPS and MES buffers were made by 
adjusting the pH using 5 M NaOH.  
 
2.4.3 Cloning of the ptxD Gene from Methylobacterium extorquens AM1 
M. extorquens AM1 (ATCC 14718) was purchased (ATCC #14718) and grown in nutrient broth 
at 30 °C for 48 h. The culture was then pelleted and the genomic DNA extracted using an Ultra 
Clean Microbial Genomic DNA Kit (MO-BIO). The gene from M. extorquens was then 
amplified from the purified genomic DNA using the following primers: 5’-
GCCAGTTCCATATGAGAGCCAAGG-3’ and 5’-CTCACACTCGAGTCACGGATGTCG-3’. 
The primers contain NdeI and XhoI restriction sites (underlined) which were used to incorporate 
the gene into pET28a. (JEH-5-13, JEH-5-18).  
 
2.4.4 Preparation of 17X-PTDH Mutant Constructs 
All mutants were generated in the 17X-PTDH background using the pET15b plasmid unless 
noted otherwise. The mutants were prepared by the polymerase chain reaction (PCR) using 
QuikChange mutagenesis (Agilent).  The following primers were used to incorporate the 
mutations (along with their reverse complement strands, which are not listed): R301K:  5'- GTG 
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CGC GCG GTG AAA CTG GAG ATT GAA C -3'; S295A: 5’-CCG CAC ATA GGG GCG 
GCA GTG CGC GCG-3’; Y139F: 5’-C TGG CAA CCA CGG TTC TTC GGC ACG GG-3’; 
W134F: 5'-GC AAG TTC CGG GGC TTC CAA CCA CGG TTC TAC-3'; W134A:  5'-GC 
AAG TTC CGG GGC GCG CAA CCA CGG TTC TAC-3'. The mutated codon is underlined in 
each case. The R301A mutant was prepared by Tyler Johannes in the Zhao group, as detailed in 
(7). Once the mutant genes were constructed, they were sequenced in their entirety to ensure that 
the desired mutation was incorporated and no other mutations were generated. (JEH-4-32, JEH-
4-55, JEH-4-73, JEH-4-93, JEH-5-85). 
 
2.4.5 Overexpression and Purification of PTDH Mutants 
To obtain mutants of 17X-PTDH, chemically competent E. coli BL21 (DE3) cells were 
transformed with plasmids containing the desired gene in pRW2 vector and plated on a LB agar 
plate containing 100 µg/mL ampicillin. A single colony was picked and used to inoculate an 
overnight culture (50 mL). The cells were harvested by centrifugation, resuspended in 1 L of 
LB/ampicillin and grown at 37 °C to OD600 nm = 0.6. IPTG was added to the culture (0.3 mM 
final concentration), which was incubated at 18 °C for 16-20 h. Cells were then pelleted by 
centrifugation (8,000 × g, 30 min), resuspended in 20 mM Tris pH 7.6, 0.5 M NaCl, 10% 
glycerol (v/v), and stored at −80 °C. The resuspended pellet was then thawed on ice and lysed 
using an Avestin Emulsiflex-C3 Homogenizer (15 kPsi, 6 passes). The insoluble lysate was 
removed by centrifugation (15,000 × g, 30 min), and the soluble lysate was passed through a 
0.44 μm filter. The enzyme was purified via FPLC (Äkta) by immobilized metal affinity 
chromatography with a HisTrap HP Ni2+-affinity column (GE Life Sciences). The column was 
washed with 5 CV of buffer A, followed by a gradient to 40% buffer B over 5 CV, and another 
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gradient of 2 CV to 100% buffer B (buffer A: 20 mM Tris pH 7.6, 100 mM NaCl, 10 mM 
imidazole, 10% glycerol (v/v); buffer B: 20 mM Tris pH 7.6, 100 mM NaCl, 500 mM imidazole, 
10% glycerol (v/v)). Fractions containing 17X-PTDH mutants were identified by activity assay 
and analyzed by SDS-PAGE. The fractions that showed only PTDH by SDS-PAGE were pooled 
and concentrated using centrifugal filtration (Amicon membrane, 30 kDa molecular weight 
cutoff; Millipore), followed by buffer exchange or dialysis to 20 mM MOPS pH 7.6, 100 mM 
KCl, 10% glycerol. Protein purity was >95% based on FPLC analysis and SDS-PAGE analysis. 
Specific activities for several independent purifications of each mutant were found to be 
comparable, further suggesting that the enzyme was highly pure. The kcat values shown in Table 
1 are the average of three independent measurements. The protein solution was then flash frozen 
and stored at −80 °C. Protein concentrations were determined in triplicate using the calculated 
extinction coefficient for 17X-PTDH, 28,000 M-1 cm-1 (31). For Trp134 mutants, the extinction 
coefficient was calculated to be 21,000 M-1 cm-1 (ExPASy ProtParam tool). For comparison, 
protein concentrations for a stock solution of 17X-PTDH were also determined by the method of 
Bradford (55), using Coomassie Plus reagent (Thermo Scientific) and bovine serum albumin 
(BSA) to generate a standard curve. Measurements were taken at 595 nm and compared to the 
standard curve to determine protein concentration, using the calculated molar mass of 17X-
PTDH. Experimental measurements were obtained in triplicate in each case. Concentrations of 
22.4 ± 1.3 µM and 22.7 ± 0.1 µM were determined by absorbance at A280 using the calculated 
extinction coefficient and the Bradford method, respectively. The concentrations determined by 
each method were within experimental error of one another. The PTDH from M. extorquens was 
purified using the same method.   
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2.4.6 Steady State Kinetic Assays 
Initial rates were determined using a Cary 4000 UV-vis spectrophotometer (Agilent) to monitor 
the rate of formation of NADH using its absorbance at 340 nm (ε = 6.2 mM-1 cm-1). Typical 
reactions were performed in 100 mM MOPS at pH 7.25. For 17X-PTDH, R301K, and R301A, a 
full set of kinetic data was collected varying both the phosphite and NAD+ concentrations 
(Figure 2.5). For 17X-PTDH the following concentrations were used for both substrates: 0.03, 
0.05, 0.07, 0.10, 0.20 and 0.50 mM and 0.0910 ± 0.0004 µM enzyme. For R301K, the NAD+ 
concentrations used were 0.02, 0.05, 0.10, 0.20, 0.50 and 1.0 mM and the phosphite 
concentrations used were 0.50, 1.0, 2.0, 5.0, 10.0 and 20.0 mM, with 0.126 ± 0.001 µM enzyme. 
For R301A, the NAD+ concentrations were 0.1, 0.2, 0.5, 1.0, 3.0 and 6.0 mM, and the phosphite 
concentrations 9.0, 18, 45, 90, 181 and 271 mM, using 4.976 ± 0.022 µM enzyme. For the other 
mutants, NAD+ was held at saturating concentrations of 4 mM (> 16 × Km,NAD) while the 
phosphite concentration was varied, or NAD+ concentrations were varied while phosphite was 
held at a saturating concentration of 2.2 mM for S295A (21 × Km,Phosphite), 9.0 mM for W134F 
(26 x Km,Phosphite), 46.5 mM for W134A (24 × Km,Phosphite), and 5.0 mM for Y139F (128 × 
Km,Phosphite). Enzyme concentrations were 0.259 ± 0.001 µM for S295A; 0.147 ± 0.001 µM for 
Y139F; 0.233 ± 0.001 μM for W134A; and 0.215 ± 0.001 μM for W134F. Error bars on kcat were 
obtained from three independently purified batches of protein.  
For the kinetic assays, reaction mixtures were allowed to equilibrate at 25 °C in a controlled 
temperature block, which was verified using a thermocouple inserted into the cuvette, and the 
reaction was initiated by addition of enzyme. Assays on the 17X-PTDH mutants were performed 
with the His6-affinity tag attached. The His-tag has been shown not to have a significant effect 
on the kinetic parameters of the enzyme in a previous study (56). Assays for PTDH orthologs 
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were performed at 30 °C. Initial rates were obtained over the course of one minute. The data 
were fit to the Michaelis-Menten equation using OriginPro 8 (OriginLab) for the orthologs and 
the mutants of Ser295, Trp134, and Tyr139 or using the equation for an ordered, sequential, two-
substrate mechanism (equation 2.1) (30) using GraFit 7 (57) for 17X-PTDH, R301A, and 
R301K. In this equation, A represents the first substrate to bind (NAD+), and B represents the 
second substrate (phosphite). KA and KB are Km,NAD and Km,Phosphite, respectively. Kia represents 
the dissociation constant for NAD+. (JEH-6-58, JEH-6-59, JEH-6-61, JEH-6-65, JEH-6-78, JEH-
6-93).  
ݒ =  ௠ܸ௔௫[A][B]ܭ௜௔ܭ஻ + ܭ஻[A] + ܭ஺[B] + [A][B]     (eq. 2.1) 
  
 
2.4.7 Kinetic Isotope Effects 
 Deuterium-labeled phosphite was prepared as reported previously (11) by mixing phosphorous 
acid with deuterium oxide at 50 °C for 6 h. The solution was then concentrated by rotary 
evaporator and the residue redissolved in deuterium oxide. This procedure was repeated until 
only deuterium-labeled phosphite was observed by 31P NMR spectroscopy (500 MHz Varian, 
H3PO4 used as external reference, δ = 0 ppm): δ 3.71 (t, JP-D = 88 Hz). The solution was then 
neutralized using aqueous NaOH and lyophilized to obtain solid deuterium labeled sodium 
phosphite. Kinetic isotope effects (KIEs) were determined by holding NAD+ at saturating 
conditions (>10 × Km) and obtaining initial rates with varying concentrations of either deuterated 
or protiated phosphite. The pH of the assay mix prior to enzyme addition was verified prior to 
initiation of the assay. (JEH-3-11, JEH-3-13, JEH-3-60, JEH-4-08, JEH-4-16, JEH-4-25).  
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2.4.8 pH Rate Profiles of 17X-PTDH Mutants 
Solutions containing 100 mM Tris, 50 mM MES, and 50 mM acetic acid, generating a universal 
buffer of constant ionic strength (38), were prepared at pH 5.5, 5.8, 6.1, 6.4, 6.7, 7.0, 7.3, 7.6, 
7.9, 8.2, 8.5, 8.8 and 9.0. NAD+ was dissolved in buffer of desired pH and phosphite stock 
solutions were adjusted to the pH of the assay. Experiments were also performed in 100 mM Tris 
maleate, a broad range buffer, as well as in 100 mM MOPS from pH 6.7 to pH 7.7. NAD+ was 
held at saturating conditions (>10 × Km), whereas phosphite concentrations were varied from 
0.05-1500 mM (for 17X-PTDH-R301A), 0.5-500 mM (for 17X-PTDH-R301K), and 0.15-50 
mM (for 17X-PTDH).  The concentrations of phosphite used at each pH varied according to the 
Km,Phosphite at that pH, ranging from approximately 0.2 × Km to >10 × Km,Phosphite. Reactions were 
mixed and allowed to equilibrate for several minutes to adjust the temperature and ensure 
homogeneity until the baseline absorbance at 340 nm remained constant. Reactions were 
initiated by addition of 17X-PTDH (0.16 µM final), 17X-PTDH-R301K (0.08 µM final), or 
17X-PTDH-R301A (3-6 μM final). Initial rates of NADH formation were monitored at 340 nm 
using a Cary 4000 spectrophotometer.  Kinetic parameters were determined from fits to the 
Michaelis-Menten equation using OriginPro 8, and pKa values were determined by fitting 
logarithmic plots of kcat and kcat/Km to the equation for curves with one or two proton transitions 
(equations 2.2 and 2.3, respectively) (58), with K1, K2, and (kcat/K)0  representing dependent 
variables that are calculated by fitting of the data. K1 represents the acid dissociation constant for 
a proton transition that increases activity upon deprotonation (ascending limb) and K2 represents 
the acid dissociation constant for a proton transition that decreases activity upon deprotonation 
(descending limb);  (kcat/K)0 is a pH-independent value. (JEH-3-44, JEH-6-38, JEH-6-43, JEH-6-
46) 
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log ൬݇௖௔௧ܭ௠ ൰ = log ൮
ቀ݇௖௔௧ܭ௠ ቁ଴
1 + [ܪା]ܭଵ
൲     (eq. 2.2) 
   
 
log ൬݇௖௔௧ܭ௠ ൰ = log ൮
ቀ݇௖௔௧ܭ௠ ቁ଴
1 + [ܪା]ܭଵ +
ܭଶ[ܪା]
൲     (eq. 2.3) 
   
 
2.4.9 Gel Filtration Experiments 
Gel filtration experiments were performed on a BioSil SEC-250 (BioRad) HPLC gel filtration 
column using a buffer composed of 100 mM MOPS pH 7.3, 0.4 M sodium phosphite. Albumin, 
alcohol dehydrogenase, β-amylase, blue dextran, carbonic anhydrase, and cytochrome C 
standards (Sigma-Aldrich) were used to generate a standard curve. 17X-PTDH-R301A and 17X-
PTDH were run on the column with and without 5 mM NAD+. The retention time was 
unaffected by the presence of cofactor. The elution time compared to that of the standards was 
used to determine the oligomerization states of the proteins. (JEH-3-97). 
 
2.4.10 Protein Crystallography of Arg301Ala and Arg301Lys 
To remove the His6-affinity tag, thrombin (MP Biomedicals, 1 U / mg PTDH) was added to the 
Ni2+-affinity purified protein during overnight dialysis at 4 °C. The cleavage product was 
purified by FPLC with a Superdex 200 gel filtration column (GE Healthcare) in 20 mM HEPES 
with 100 mM KCl (pH 7.5). The cleaved protein was determined to be >95% pure by SDS-
58 
 
PAGE and FPLC analysis and full activity was observed for each His-tag-cleaved mutant by 
steady-state kinetic assay.  
Crystals of both PTDH variants were grown using the hanging drop method.  Following gel-
filtration, samples of each variant were concentrated to 10 mg/mL and incubated with 10 mM 
NAD+ for 30 min and then equilibrated against a reservoir of 0.1 M NaCl, 0.1 M sodium 
cacodylate pH 5.8, 16% PEG 6000 (w/v) (for R301K) or 0.1 M ammonium acetate, 0.1 M Bis 
Tris pH 5.5, 17% PEG 10000 (w/v) (for R301A, performed by Neha Garg). Crystallization 
samples were incubated at 288 K for 5-7 days. Prior to data collection, crystals of each PTDH 
variant were briefly immersed into a solution composed of the crystallization media 
supplemented with 20% (v/v) glycerol and vitrified by direct immersion into liquid nitrogen. The 
crystals were diffracted and the data solved by Jonathan Chekan and Professor Satish Nair; final 
data collection and crystallographic statistics are detailed in (43). (JEH-7-96).  
 
2.4.11 Chemical Rescue Experiments with 17X-PTDH-R301A 
The initial rates with and without rescue agent were determined at 25 °C. Typical reactions were 
conducted in 100 mM MOPS pH 7.25, and contained 1 µM 17X-PTDH-R301A, 4 mM NAD+ 
(saturated), a defined concentration of rescue reagent, and varying phosphite concentrations. 
Control experiments showed that activity above background was only observed when enzyme, 
NAD+, phosphite and rescue agent were present. At several different concentrations of rescue 
reagent, phosphite concentration was varied to obtain a Michaelis-Menten curve from which the 
maximal activity at each concentration of rescue reagent (kcat,apparent) was extracted. The values of 
kcat,apparent so determined were then plotted against the concentration of rescue reagent and fit to 
equation 2.4 (44, 59) to obtain KR, the concentration of rescue reagent at which half-maximal 
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rate was observed, and krescue (kcat,apparent under conditions of saturating rescue reagent). The 
purity of the rescue reagent was verified prior to running assays by 13C NMR analysis. The 
apparent Km,Phosphite was determined by holding the concentration of rescue agent and NAD+ at 
saturating conditions (>10 × KR) and varying the concentration of phosphite. Addition of rescue 
reagent at this concentration to the reaction catalyzed by the parent 17X-PTDH had no effect on 
activity. The compounds tested as rescue agents were acetamidine, guanidine, methylguanidine, 
aminoguanidine, ethylguanidine, nitroguanidine, N-guanylurea, methylamine, and ethylamine. 
Other compounds, including urea, hydroxyurea, thiourea, n-butylamine, and imidazole were 
tested by Dr. Emily Fogle (43). A Brønsted plot was constructed by plotting the pKa values of the 
conjugate acids of the successful rescue agents against )/log( BaseRrescue Kk (Equation 2.5), where 
Base
RK  is the KR parameter, corrected for free base concentration at pH 7.25 (32, 44), and β is the 
Brønsted coefficient. (JEH-5-87, JEH-5-89, JEH-5-91, JEH-7-53) 
 
kcat,apparent = (krescue[rescue reagent])/(KR + [rescue reagent]) + kcat,R301A    (eq. 2.4) 
CpKKk a
Base
Rrescue += )()/log( β     (eq. 2.5) 
 
2.4.12 pH Dependence of Chemical Rescue 
Reactions were performed at 0, 0.5, 1.0, 1.5, or 2.0 mM aminoguanidine sulfate or guanidine 
HCl in 100 mM MOPS at pH 7.0, 7.5, and 8.0. These concentrations were selected as they are 
less than ½ KR and would be within the initial linear region of a square hyperbola for recovery of 
activity. NAD+ concentration was held at 4 mM, which was verified to be saturating at each pH 
value and at all concentrations of rescue reagent used. Phosphite was similarly held at saturating 
conditions of 1 M. For the pH rate profile of R301A with aminoguanidine, saturating 
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concentrations of 1 M rescue reagent were utilized at each pH value, and the experiment was 
performed as detailed in section 2.4.8. (JEH-5-56, JEH-8-10, JEH-8-22, JEH-8-28). 
 
2.4.13 Solvent Isotope Effect Experiments on 17X-PTDH-R301A 
All buffers and reagents were prepared in D2O and adjusted by addition of DCl or NaOD, 
according to pD = pH-reading + 0.4. Sodium phosphite hexahydrate salt was dissolved in D2O 
(25 mL) to create a 0.5 M stock and the pH was adjusted to the desired value. The solution was 
then lyophilized and resuspended in D2O, and this procedure was repeated twice. The enzyme 
was diluted from a stock solution into 100 mM MOPS in D2O (1:10 dilution of enzyme, 30 min 
on ice). The reactions were performed in 100 mM MOPS with 4 mM NAD+ at pD 7.25 and 
initiated by addition of 4 µM R301A-PTDH. To obtain the solvent isotope effect, the rate 
constants observed in D2O were directly compared with those obtained from the reaction 
performed in H2O at pH 7.25. Following the reaction, the stock of phosphite in D2O was 
analyzed by 31P NMR spectroscopy to verify no 2H-phosphite was formed during the incubation 
period. (JEH-5-57).  
 
2.4.14 Kinetic Isotope Effects for Chemical Rescue Experiments 
Deuterium-labeled phosphite was prepared as reported previously in section 2.4.7. Kinetic 
isotope effects (KIEs) were determined by holding NAD+ at saturating conditions of 4 mM and 
obtaining initial rates with varying concentrations of either deuterated or protiated phosphite. 
Experiments were performed in 100 mM MOPS (pH 7.25) at 25 °C with saturating amounts 
(>20 × KR) of rescue reagent. Apparent Michaelis-Menten constants were obtained from these 
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data. The ratios of the apparent rate constants kcat and kcat/Km for labeled and unlabeled phosphite 
yielded Dkcat and D(kcat/Km), respectively.  
The overall isotope effect on the Brønsted rescue plot was determined by holding phosphite or 
deuterium-labeled phosphite at saturating concentrations (>10 × Km) and varying the 
concentration of each rescue reagent. A Brønsted plot was generated for each isotopologue of 
phosphite and the Brønsted constant, β, was determined as described above. (JEH-7-22, JEH-7-
65).  
 
2.4.15 Sulfite Inhibition Studies with 17X-PTDH-R301A 
Reactions were performed in 100 mM MOPS (pH 7.25) at saturating concentrations of 4 mM 
NAD+. Sodium sulfite was adjusted to the desired concentration by serial dilution from a 0.5 M 
stock solution. Sulfite concentration was adjusted to 0, 50, 100, 150, 200 or 300 µM for R301A; 
0, 50, 100, 300 or 600 µM for R301K; or 0, 0.5, 1, 5, 10 or 20 µM for 17X-PTDH. An 
experiment was also performed with 17X-PTDH-R301A and saturating concentrations of 300 
mM aminoguanidine, with sulfite concentrations of 0, 100, 200, 300, 400 or 500 µM. The 
reaction was initiated by addition of PTDH (0.1 µM final concentration, or 5 µM for R301A). At 
each concentration of inhibitor, phosphite concentration was varied. The data was analyzed in 
GraFit 7.0 (57) using the equation for competitive inhibition (Equation 2.6) to fit all of the data, 
where I is the inhibitor concentration and Kis is the dissociation constant for a competitive 
inhibitor (29). (JEH-6-31, JEH-6-34, JEH-6-35, JEH-7-33, JEH-8-20) 
ݒ =  ௏೘ೌೣ[ௌ]
௄೘൬ଵା [಺]಼೔ೞ൰ା[ௌ]
   (eq. 2.6)  
62 
 
2.5 References 
1. Zou, Y., Zhang, H., Brunzelle, J. S., Johannes, T. W., Woodyer, R. D., Hung, J. E., Nair, 
N., van der Donk, W. A., Zhao, H., and Nair, S. K. (2012) Crystal structures of phosphite 
dehydrogenase provide insights into nicotinamide cofactor regeneration, Biochemistry 51, 
4263-4270. 
2. Costas, A. M., White, A. K., and Metcalf, W. W. (2001) Purification and characterization 
of a novel phosphorus-oxidizing enzyme from Pseudomonas stutzeri WM88, J. Biol. 
Chem. 276, 17429-17436. 
3. Woodyer, R., Wheatley, J., Relyea, H., Rimkus, S., and van der Donk, W. A. (2005) Site-
directed mutagenesis of active site residues of phosphite dehydrogenase, Biochemistry 
44, 4765-4774. 
4. Taguchi, H., and Ohta, T. (1991) D-lactate dehydrogenase is a member of the D-isomer-
specific 2-hydroxyacid dehydrogenase family. Cloning, sequencing, and expression in 
Escherichia coli of the D-lactate dehydrogenase gene of Lactobacillus plantarum, J. Biol. 
Chem. 266, 12588-12594. 
5. Taguchi, H., and Ohta, T. (1993) Histidine 296 is essential for the catalysis in 
Lactobacillus plantarum D-lactate dehydrogenase, J. Biol. Chem. 268, 18030-18034. 
6. Goldberg, J. D., Yoshida, T., and Brick, P. (1994) Crystal structure of a NAD-dependent 
D-glycerate dehydrogenase at 2.4 A resolution, J. Mol. Biol. 236, 1123-1140. 
7. Hung, J. E., Fogle, E. J., Christman, H. D., Johannes, T. W., Zhao, H. M., Metcalf, W. 
W., and van der Donk, W. A. (2012) Investigation of the role of Arg301 identified in the 
X-ray structure of phosphite dehydrogenase, Biochemistry 51, 4254-4262. 
63 
 
8. Hirota, R., Yamane, S., Fujibuchi, T., Motomura, K., Ishida, T., Ikeda, T., and Kuroda, 
A. (2012) Isolation and characterization of a soluble and thermostable phosphite 
dehydrogenase from Ralstonia sp. strain 4506, J. Biosci. Bioeng. 113, 445-450. 
9. Liu, D.-F., Ding, H.-T., Du, Y.-Q., Zhao, Y.-H., and Jia, X.-M. (2012) Cloning, 
expression, and characterization of a wide-pH-range stable phosphite dehydrogenase 
from Pseudomonas sp. K in Escherichia coli, Appl. Biochem. Biotech. 166, 1301-1313. 
10. Martínez, A., Osburne, M. S., Sharma, A. K., DeLong, E. F., and Chisholm, S. W. (2012) 
Phosphite utilization by the marine picocyanobacterium Prochlorococcus MIT9301, 
Environ. Microbiol. 14, 1363-1377. 
11. Relyea, H. A., Vrtis, J. M., Woodyer, R., Rimkus, S. A., and van der Donk, W. A. (2005) 
Inhibition and pH dependence of phosphite dehydrogenase, Biochemistry 44, 6640-6649. 
12. Guillén Schlippe, Y. V., and Hedstrom, L. (2005) Is Arg418 the catalytic base required 
for the hydrolysis step of the IMP dehydrogenase reaction?, Biochemistry 44, 11700-
11707. 
13. Guillén Schlippe, Y. V., and Hedstrom, L. (2005) A twisted base? The role of arginine in 
enzyme-catalyzed proton abstractions, Arch. Biochem. Biophys. 433, 266-278. 
14. Hedstrom, L., and Gan, L. (2006) IMP dehydrogenase: structural schizophrenia and an 
unusual base, Curr. Opin. Chem. Biol. 10, 520-525. 
15. Bossi, R. T., Negri, A., Tedeschi, G., and Mattevi, A. (2002) Structure of FAD-bound L-
aspartate oxidase: insight into substrate specificity and catalysis, Biochemistry 41, 3018-
3024. 
64 
 
16. Tedeschi, G., Ronchi, S., Simonic, T., Treu, C., Mattevi, A., and Negri, A. (2001) 
Probing the active site of L-aspartate oxidase by site-directed mutagenesis: role of basic 
residues in fumarate reduction, Biochemistry 40, 4738-4744. 
17. Charnock, S. J., Brown, I. E., Turkenburg, J. P., Black, G. W., and Davies, G. J. (2002) 
Convergent evolution sheds light on the anti-beta -elimination mechanism common to 
family 1 and 10 polysaccharide lyases, Proc. Natl. Acad. Sci. U. S. A. 99, 12067-12072. 
18. Mowat, C. G., Moysey, R., Miles, C. S., Leys, D., Doherty, M. K., Taylor, P., 
Walkinshaw, M. D., Reid, G. A., and Chapman, S. K. (2001) Kinetic and crystallographic 
analysis of the key active site acid/base arginine in a soluble fumarate reductase, 
Biochemistry 40, 12292-12298. 
19. Doherty, M. K., Pealing, S. L., Miles, C. S., Moysey, R., Taylor, P., Walkinshaw, M. D., 
Reid, G. A., and Chapman, S. K. (2000) Identification of the active site acid/base catalyst 
in a bacterial fumarate reductase: a kinetic and crystallographic study, Biochemistry 39, 
10695-10701. 
20. Scavetta, R. D., Herron, S. R., Hotchkiss, A. T., Kita, N., Keen, N. T., Benen, J. A., 
Kester, H. C., Visser, J., and Jurnak, F. (1999) Structure of a plant cell wall fragment 
complexed to pectate lyase C, Plant Cell 11, 1081-1092. 
21. Sanchez-Torres, P., Visser, J., and Benen, J. A. (2003) Identification of amino acid 
residues critical for catalysis and stability in Aspergillus niger family 1 pectin lyase A, 
Biochem. J. 370, 331-337. 
22. Wilson, M. M., and Metcalf, W. W. (2005) Genetic diversity and horizontal transfer of 
genes involved in oxidation of reduced phosphorus compounds by Alcaligenes faecalis 
WM2072, Appl. Environ. Microbiol. 71, 290-296. 
65 
 
23. Lanzetta, P. A., Alvarez, L. J., Reinach, P. S., and Candia, O. A. (1979) An improved 
assay for nanomole amounts of inorganic phosphate, Anal. Biochem. 100, 95-97. 
24. Taguchi, H., Ohta, T., and Matsuzawa, H. (1997) Involvement of Glu-264 and Arg-235 
in the essential interaction between the catalytic imidazole and substrate for the D-lactate 
dehydrogenase catalysis, J. Biochem. 122, 802-809. 
25. Taguchi, H., and Ohta, T. (1994) Essential role of arginine 235 in the substrate-binding of 
Lactobacillus plantarum D-lactate dehydrogenase, J. Biochem. 115, 930-936. 
26. Yoshida, T., Yamaguchi, K., Hagishita, T., Mitsunaga, T., Miyata, A., Tanabe, T., Toh, 
H., Ohshiro, T., Shimao, M., and Izumi, Y. (1994) Cloning and expression of the gene for 
hydroxypyruvate reductase (D-glycerate dehydrogenase from an obligate methylotroph 
Hyphomicrobium methylovorum GM2, Eur. J. Biochem. 223, 727-732. 
27. Tobey, K. L., and Grant, G. A. (1986) The nucleotide sequence of the serA gene of 
Escherichia coli and the amino acid sequence of the encoded protein, D-3-
phosphoglycerate dehydrogenase, J. Biol. Chem. 261, 12179-12183. 
28. Bernard, N., Ferain, T., Garmyn, D., Hols, P., and Delcour, J. (1991) Cloning of the D-
lactate dehydrogenase gene from Lactobacillus delbrueckii subsp. bulgaricus by 
complementation in Escherichia coli, FEBS Lett. 290, 61-64. 
29. Cook, P. F., and Cleland, W. W. (2007) Enzyme Kinetics and Mechanism, Garland 
Science, New York. 
30. Cleland, W. W. (1979) Statistical analysis of enzyme kinetic data, Methods Enzymol. 63, 
103-138. 
66 
 
31. Fogle, E. J., and van der Donk, W. A. (2007) Pre-steady-state studies of phosphite 
dehydrogenase demonstrate that hydride transfer is fully rate limiting, Biochemistry 46, 
13101-13108. 
32. Guillén Schlippe, Y. V., and Hedstrom, L. (2005) Guanidine derivatives rescue the 
Arg418Ala mutation of Tritrichomonas foetus IMP dehydrogenase, Biochemistry 44, 
16695-16700. 
33. Min, D., Josephine, H. R., Li, H., Lakner, C., MacPherson, I. S., Naylor, G. J., Swofford, 
D., Hedstrom, L., and Yang, W. (2008) An enzymatic atavist revealed in dual pathways 
for water activation, PLoS Biol. 6, e206. 
34. Craik, C., Roczniak, S., Largman, C., and Rutter, W. (1987) The catalytic role of the 
active site aspartic acid in serine proteases, Science 237, 909-913. 
35. Hamilton, C. S., Spedaliere, C. J., Ginter, J. M., Johnston, M. V., and Mueller, E. G. 
(2005) The roles of the essential Asp-48 and highly conserved His-43 elucidated by the 
pH dependence of the pseudouridine synthase TruB, Arch. Biochem. Biophys. 433, 322-
334. 
36. Plapp, B. V. (1995) Site-directed mutagenesis: a tool for studying enzyme catalysis, 
Methods Enzymol. 249, 91-119. 
37. Howell, E. E., Villafranca, J. E., Warren, M. S., Oatley, S. J., and Kraut, J. (1986) 
Functional role of aspartic acid-27 in dihydrofolate reductase revealed by mutagenesis, 
Science 231, 1123-1128. 
38. Ellis, K. J., and Morrison, J. F. (1982) Buffers of constant ionic strength for studying pH-
dependent processes, Methods Enzymol. 87, 405-426. 
67 
 
39. Sims, P. A., Larsen, T. M., Poyner, R. R., Cleland, W. W., and Reed, G. H. (2003) 
Reverse protonation is the key to general acid-base catalysis in enolase, Biochemistry 42, 
8298-8306. 
40. Bevilacqua, P. C. (2003) Mechanistic considerations for general acid-base catalysis by 
RNA: revisiting the mechanism of the hairpin ribozyme, Biochemistry 42, 2259-2265. 
41. Vrtis, J. M., White, A., Metcalf, W. W., and van der Donk, W. A. (2001) Phosphite 
dehydrogenase: an unusual phosphoryl transfer reaction, J. Am. Chem. Soc. 123, 2672-
2673. 
42. Relyea, H. A. (2006) Kinetic Analysis and pH Dependence of the Phosphite 
Dehydrogenase Reaction, PhD Dissertation, University of Illinois, Urbana. 
43. Hung, J. E., Fogle, E. J., Garg, N., Chekan, J. R., Nair, S. K., and van der Donk, W. A. 
Chemical rescue and inhibition studies to determine the role of Arg301 in phosphite 
dehydrogenase, In preparation. 
44. Toney, M. D., and Kirsch, J. F. (1989) Directed Brønsted analysis of the restoration of 
activity to a mutant enzyme by exogenous amines, Science 243, 1485-1488. 
45. Rynkiewicz, M. J., and Seaton, B. A. (1996) Chemical rescue by guanidine derivatives of 
an arginine-substituted site-directed mutant of Escherichia coli ornithine 
transcarbamylase, Biochemistry 35, 16174-16179. 
46. Perrin, D. D. (1965) Dissociation Constants of Organic Bases in Aqueous Solution, 
Butterworths, London. 
47. Lehoux, I. E., and Mitra, B. (2000) Role of arginine 277 in (S)-mandelate dehydrogenase 
from Pseudomonas putida in substrate binding and transition state stabilization, 
Biochemistry 39, 10055-10065. 
68 
 
48. Hansch, C., and Leo, A. (1979) Substituent constants for correlation analysis in 
chemistry and biology, Wiley. 
49. Jencks, W. P. (1987) Catalysis in Chemistry and Enzymology, Dover, New York. 
50. Harpel, M. R., and Hartman, F. C. (1994) Chemical rescue by exogenous amines of a 
site-directed mutant of ribulose 1,5-bisphosphate carboxylase/oxygenase that lacks a key 
lysyl residue, Biochemistry 33, 5553-5561. 
51. Klinman, J. P., and Matthews, R. G. (1985) Calculation of substrate dissociation 
constants from steady-state isotope effects in enzyme-catalyzed reactions, J. Am. Chem. 
Soc. 107, 1058-1060. 
52. Northrop, D. B. (1998) On the meaning of Km and V/K in enzyme kinetics, J. Chem. 
Educ. 75, 1153-1157. 
53. Woodyer, R., van der Donk, W. A., and Zhao, H. (2006) Optimizing a biocatalyst for 
improved NAD(P)H regeneration: Directed evolution of phosphite dehydrogenase, 
Comb. Chem. High Throughput Screen. 9, 237-245. 
54. Johannes, T. W., Woodyer, R. D., and Zhao, H. M. (2005) Directed evolution of a 
thermostable phosphite dehydrogenase for NAD(P)H regeneration, Appl. Environ. 
Microbiol. 71, 5728-5734. 
55. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72, 
248-254. 
56. Woodyer, R., van der Donk, W. A., and Zhao, H. (2003) Relaxing the nicotinamide 
cofactor specificity of phosphite dehydrogenase by rational design, Biochemistry 42, 
11604-11614. 
69 
 
57. Leatherbarrow, R. J. (2009) GraFit Version 7,  7.0 ed., Erithacus Software Limited, 
Horley, UK. 
58. Cleland, W. W. (1982) The use of pH studies to determine chemical mechanisms of 
enzyme-catalyzed reactions, Methods Enzymol. 87, 390-405. 
59. Goedl, C., and Nidetzky, B. (2008) The phosphate site of trehalose phosphorylase from 
Schizophyllum commune probed by site-directed mutagenesis and chemical rescue 
studies, FEBS J. 275, 903-913. 
 
 
 
70 
 
CHAPTER 3: THE CATALYTIC ROLE OF MET53 IN THE PTDH REACTION 
 
3.1 Introduction 
Met53 was first identified as a potentially important catalytic residue during analysis of the 
X-ray crystal structures of PTDH from P. stutzeri (1). When comparing the co-crystal structures 
of TS-PTDH-NAD (PDB: 4E5N) and TS-PTDH-NAD-sulfite (PDB: 4E5K), the orientation of 
Met53 was observed to shift upon binding of sulfite, a competitive inhibitor (2), resulting in an 
apparent interaction between the sulfur of the methionine and an oxygen atom from sulfite with a 
bond distance of 3.1 Å in the ternary structure (Figure 3.1). This interaction was initially 
characterized as a putative hydrogen bond, as the distance and orientation between lone-pair 
electrons on the sulfur and the oxygen (if protonated) were appropriate. As such, the methionine 
residue was suspected of playing a potential catalytic role.   
Met53 is fully conserved among all confirmed PTDHs (3) (Figure 3.2). While methionine 
residues are most commonly associated with hydrophobic interactions and steric effects in 
proteins, methionine has also been reported to act as a hydrogen bond acceptor to the backbone 
amide NH in proteins (4) and it can also act to stabilize residues through non-hydrogen bond 
interactions with other residues (5). In addition, the residue sometimes serves as a ligand for 
metal ions (6, 7). However, examples of methionine playing a direct role in enzyme-mediated 
catalysis are rare (8), and no examples are known where the residue plays a defined catalytic 
role.  
 
This chapter contains material adapted from:  
Ranaghan, K. E., Hung, J. E., Bartlett, G. J., Mooibroek, T. J., Woolfson, D. N., van der Donk, W. A., 
and Mulholland, A. J. A catalytic role for methionine revealed by a combination of computation and 
experiments on phosphite dehydrogenase. Submitted.  
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In order to determine the catalytic role of Met53, a multidisciplinary approach was adopted, 
combining experiments with mechanistic modeling performed by the Mulholland laboratory 
(University of Bristol, UK). This type of synergistic strategy has become more common in recent 
years to answer questions about enzyme mechanisms that have been difficult to elucidate 
through experimentation alone (9-12). Met53 was investigated through experiments, including 
mutagenesis and pH profiles, and computational quantum mechanics/molecular mechanics 
(QM/MM) modeling in order to determine its catalytic role. 
 
 
Figure 3.1. A representation of the crystal structures of TS-PTDH with the NAD+ co-factor and 
sulfite inhibitor in green and the complex without sulfite in blue. NAD+ and several key active 
site residues are shown as sticks: Arg237, His292 and Met53 and their interactions with the 
sulfite inhibitor are indicated by dotted lines. Arg237 is important for binding of the substrate 
and His292 is the putative base for the reaction (13). When sulfite is present the (Met) sulfur to 
(sulfite) oxygen distance is 3.1 Å and in the absence of sulfite the side chain of Met53 adopts a 
different orientation. This figure is adapted from (14).  
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Figure 3.2. Partial sequence alignment of several active PTDH orthologs from different 
organisms. The orthologs exhibit high sequence diversity, with 39-72% overall pairwise identity 
(see Chapter 2). The PTDH from P. stutzeri corresponds to the wild-type PTDH from which 
17X-PTDH was developed. Conserved residues are highlighted in yellow. Highlighted in red is 
the Met53.  
 
3.2 Results and Discussion 
3.2.1 Computational Experiments to Determine the Role of Met53  
In order to determine the catalytic role of the Met53 residue in PTDH, a computational 
QM/MM model was developed by Kara Ranaghan in the Mulholland group (14). The reaction 
was modeled as an associative process in which nucleophilic attack by hydroxide onto phosphite 
first formed a pentavalent intermediate, which was then followed by hydride transfer to form the 
NADH and phosphate final products (Figure 3.3). From these models, a putative role of Met53 
was hypothesized that was evaluated through experimental efforts (see below).  
To summarize, in this scenario His292 acts as the active site base to deprotonate the water 
nucleophile, leading to the pentavalent phosphorane intermediate. In the next step of the reaction, 
Met53 acts to stabilize the His292 imidazolium through an nπ* interaction (15) in the second 
transition state (Figure 3.4), offering – 7.9 kcal/mol of stabilization (14). In this model, the lone 
pair electrons (n) of the sulfur atom interact with the antibonding orbitals of the histidine (π*) in 
a “face-on” interaction to stabilize the complex. Similar nπ* interactions have previously been 
noted in protein backbones (15) and model peptide systems (16). Although a hydrogen bonded 
complex appeared to be present in the crystal structure and gas phase calculations of 
methylthioethane and the His292 imidazole ring indicated that the hydrogen-bonded complex 
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would have offered significant stabilizing energy, steric constraints from other active site 
residues prevented this complex from being seen in the QM/MM simulation (14). Gas phase 
calculations were also performed on a methylselenoethane complex, which resulted in similar 
results to the methylthioethane. In addition to this nπ* interaction, a C–H–O hydrogen bond is 
formed between the methyl group of Met53 and the amide oxygen of the NAD+ cofactor (Figure 
3.4). In order to support the computational hypothesis of the role of Met53, experiments were 
performed, including mutagenesis, pH dependence, and isotope effect studies.  
 
 
Figure 3.3. An associative mechanism for the nucleophilic displacement reaction catalyzed by 
PTDH (17). TS1 and TS2 are the transition states for the first and second steps. Adapted from 
(14).  
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the mass spectra for each case, ions corresponding to full incorporation of the methionine analog 
were observed, while the ions corresponding to full or partial incorporation of methionine into 
the fragments were not observed, indicating that the residue 53 in each of the proteins was fully 
substituted with the analog. For SeMet-17X-PTDH, the fragments all contain a complex isotopic 
pattern indicative of selenium incorporation, as selenium has five stable naturally occurring 
isotopes (23). As such, the mass spectrometric analysis suggests that the protein contains full 
incorporation of SeMet at the Met53 site. When 17X-PTDH was subjected to peptidic digest as a 
control, ions corresponding to full incorporation of methionine were observed when digested 
with either protease. Global substitution of Met with its oxygen analog, O-methyl homoserine 
(also known as methoxinine), was also attempted. However, this incorporation was unsuccessful 
due to lack of growth of the bacterial culture when supplemented with the amino acid, probably 
because of the known toxicity of the analog (24).  
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Figure 3.5. MS analysis of trypsin-digested PTDHs. (a) ESI-MS spectrum of Nle-17X-PTDH 
digested by trypsin indicating the incorporation of 3 norleucines at position X in the peptide 
fragment 45-DAQAXXAFXPDR-56 (M+H = 1330) (red). Also shown are the expected m/z 
values of fragments containing 1, 2 or 3 methionines (M+H = 1348, 1366 or 1384). Shown as a 
control is the peptide fragment from the tryptic digest of 17X-PTDH, which contains 3 
methionines (black). The crude spectra were deconvoluted to obtain M+H charge states. (b) 
MALDI-MS spectrum of SeMet-17X-PTDH digested with GluC. Along with other ions, 
diagnostic ions were observed that correspond to the peptide fragment   39-
ILRRCRDAQAXXAFXPDRVDADFLQACPE-67 containing 3 selenomethionines at position X 
(M+H =3513 Da). Another ion containing Se is observed at 3495 (M+H – 18) that is a 
dehydration product, likely formed in the mass spectrometer. No ions are visible corresponding 
to 1 or 2 incorporated methionines (M+H = 3417, 3465 Da respectively).  
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3.2.3 Mutagenesis Studies on Met53 
The presence of the hydrogen bond between sulfite and Met53 observed in the crystal 
structure of the ternary complex suggested a possible role for Met53 in catalysis by PTDH, and 
the residue was therefore targeted in mutagenesis experiments. The Met53 mutants were 
constructed in the 17X-PTDH background, heterologously expressed in E. coli and purified by 
immobilized metal affinity chromatography. Steady-state kinetic analysis was carried out on the 
mutants to determine their activity relative to the parent 17X mutant (Table 3.1). Interestingly, 
while the Km values for phosphite and NAD+ exhibited relatively small variation from 17X-
PTDH, kcat was reduced ~ 50 to 200-fold for the Met53Ala and Met53Asn mutants. The loss in 
kcat was more pronounced when larger functional groups were introduced, as the Met53Ala 
mutation showed a smaller decrease in kcat than the bulkier Met53Asn mutant. In addition, the 
Met53Leu mutation, which contains a sterically large hydrophobic residue, exhibited a ~ 3750-
fold reduced kcat.  These observations suggested that packing and/or orientation in the active site 
was disrupted by the mutations, although this effect was not reflected in the Km for phosphite, 
suggesting that binding affinity was not affected. Minimal effect was also observed on Km,NAD in 
the mutants.  
In order to minimize the change to the steric environment of the active site, two non-
proteinogenic amino acids that are structural analogs of methionine were globally installed in the 
place of methionine (as discussed in section 3.2.2): norleucine and selenomethionine, which 
contain a methylene group and selenium atom in place of the sulfur, respectively. Nle-17X-
PTDH displayed only a slightly improved kcat relative to the Met53Ala mutant, suggesting that 
some interaction with Met53 (e.g. a hydrogen bond or electrostatic interaction) is disrupted, as 
opposed to only a change in the steric environment of the active site. 17X-PTDH contains eight 
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total methionine residues which would be substituted, including one in the hexa-histidine tag. In 
the crystal structure, only Met53 is near the active site so we attribute the change in kcat for Nle-
17X-PTDH to the replacement of Met53 with Nle. This conclusion is supported by the kinetic 
parameters of Nle-17X-PTDH-Met53Ala, which are similar to those observed for the Met53Ala 
mutant. SeMet-17X-PTDH exhibited a very similar kcat to 17X-PTDH. This observation was 
consistent with the computational results obtained by our collaborators. When the 4-methyl 
imidazole/imidazolium (representing His292) was modeled with either methylthioethane 
(representing Met53) or methylselenoethane (representing SeMet53) in the gas phase, the 
interaction energies were found to differ by less than 1 kcal/mol from one another (see section 
3.2.1) (14).  
The conformation of the methionine analogs in the active site structure was also considered. 
In the PTDH crystal structure, Met53 has a gauche-like conformation, with dihedral angles (for 
the Cβ-Cγ-Sδ-Cε bond) of ~ 74° and ~ 39° for the PTDH-NAD-sulfite ternary complex and the 
PTDH-NAD binary complex, respectively (Figure 3.6). In the QM/MM model developed by our 
collaborators, similar gauche-like angles were observed (14). These results are consistent with 
the known conformation of methionine residues in that all rotamers are allowed, with the gauche 
conformation slightly favored (25). While the crystal structure of SeMet-17X-PTDH shows that 
selenomethionine takes a similar gauche conformation as Met53 (1), norleucine would be 
sterically favored to be in the anti-conformation (25). Therefore, we cannot rule out that the 
different conformational preference of Nle plays a role in reducing kcat by disrupting the active 
site geometry. However, the comparable activity of Nle-17X-PTDH and the Met53Ala mutant 
suggests that loss of the side chain sulfur is more important.  
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which it is rate limiting. This observation is consistent with Met53 playing a stabilizing role in 
the transition state of the hydride transfer step, as discussed in section 3.2.1.  
 
Table 3.1.  Steady-state kinetic parameters and KIEs for Met53 mutants of PTDH. Errors in 
parentheses were obtained from fitting to the Michaelis Menten equation. PT refers to phosphite. 
ND = not determined. Adapted from (14).  
 kcat (s−1) 
Relative 
kcat 
Km,PT 
(µM) 
Km,NAD 
(µM) 
kcat/Km,PT 
(M−1s−1) 
Dkcat Dkcat/Km 
17X-
PTDH 
3.1  
(0.1) 1.00 
28  
(7) 
22 
(6) 
1.1 (0.3) 
x 105 
2.3  
(0.1) 
2.1 
(0.2) 
M53N 0.016 (0.001) 0.005 
17  
(1) 
64  
(1) 
920 
(70) ND ND 
M53A 0.059 (0.001) 0.019 
100 
 (10) 
17  
(1) 
590 
(30) 
1.9 
 (0.1) 
1.9  
(0.1) 
M53L 0.00081 (0.00005) 0.0003 
51  
(21) ND 
15  
(7) ND ND 
Nle−17X
-PTDH 
0.11 
(0.01) 0.036 
28  
(1) 
21  
(2) 
3900 
(200) 
1.8 
 (0.1) 
1.8  
(0.2) 
Nle-17X-
PTDH-
M53A 
0.072 
(0.003) 0.024 
47  
(7) 
7.8  
(0.9) 
1500 
(200) ND ND 
SeMet-
17X-
PTDH 
3.3  
(0.1) 1.07 
110 
 (10) ND 
3.4 (0.2) 
x 104 ND ND 
 
3.2.4 pH Rate Profile Studies on Met53Ala 
In order to further probe the role of Met53 in the PTDH reaction by experimental means, the 
pH dependence of the Met53Ala mutant was determined. From the pH dependence of 
log(kcat/Km,Phosphite), pKa values of 6.32 ± 0.16 and 7.21 ± 0.04 were extracted for the acidic and 
basic limbs, respectively (Figure 3.7B). These values are both skewed somewhat from the acidic 
and basic limb pKa values of 6.53 ± 0.10 and 7.9 ± 0.08 obtained for 17X-PTDH, see Chapter 2 
(3). Similar values to 17X-PTDH were obtained for wt-PTDH in a previous study (27). These 
results support that Met53 plays some role in affecting active site protonation states, particularly 
the protonation of His292 which has been attributed to the basic limb pKa (3, 27). In addition, an 
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acidic limb pKa of 4.27 ± 0.02 is observed in the log(kcat) vs. pH plot (Figure 3.7A). Although the 
original pH profile on kcat was pH independent for both 17X and wt-PTDH (Figure 2.6A), the pH 
dependence experiments had not been previously attempted at such a low pH values, and hence 
the limb was not observed. Experiments at low pH over a limited acidic pH range showed that a 
similar acidic limb pKa of 4.09 ± 0.02 for kcat is observed in 17X-PTDH (Figure 3.7C), though it 
is difficult to unambiguously assign this value due to poor buffering capacity at the low pH 
range. Although this pKa value is difficult to attribute to a particular residue, it does appear to be 
present in both the Met53Ala mutant and the parent PTDH, suggesting that Met53 does not play 
an important role in this protonation event.  
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Figure 3.7. The pH dependence of 17X-PTDH-M53A with respect to (a) log(kcat) and (b) log(kcat 
/ Km,Phosphite). (c) Also shown is the acidic range of the log(kcat) plot for 17X-PTDH. Error was 
obtained from fitting to the Michaelis-Menten equation at each pH.   
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3.3 Conclusions 
The experimental results indicate that Met53 plays an important role in PTDH catalysis. 
Methionine residues are rarely considered to be of direct catalytic importance, but mutational 
analysis of Met53 has shown it to play a significant role. Met53 is fully conserved among all 
known PTDHs, and mutation of the residue to other canonical amino acids greatly reduced kcat 
without significantly altering Km for either substrate. Computational models performed by Kara 
Ranaghan in the Mulholland laboratory (14) suggested that Met53 directly stabilizes the 
transition state of the hydride transfer step through an nπ* interaction between the Met53 
sulfur and the His292 imidazolium, resulting in 7.9 kcal/mol of stabilization energy.  
Overall, this hypothesis is consistent with the experimental results. When norleucine, a 
structural analog of methionine with a methylene group in place of the sulfur, was substituted, 
similar loss of activity was observed as with the M53A mutant. In contrast, when 
selenomethionine was substituted, the selenium atom allowed for full activity to be retained. 
These observations suggest that the sulfur atom of Met53 (or selenium in SeMet-17X-PTDH) is 
catalytically important. The lower KIEs observed with the Met53 mutants compared to the parent 
17X-PTDH suggest that the methionine affects the structure of the transition state of the rate-
limiting step or the extent to which it is rate limiting, again consistent with the computational 
model. In addition, in the pH rate profile of the M53A mutant, the pKa of the limb that is 
attributed to His292 was skewed compared to the profile of 17X-PTDH, suggesting that there 
may also be an interaction between His292 and Met53 during substrate binding events prior to 
catalysis.  
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3.4 Materials and Methods 
3.4.1 Materials 
All mutants were generated in the 17X-PTDH background (28), see Chapter 2. All chemicals 
were obtained from Sigma or Aldrich and used without further purification unless otherwise 
noted.  
 
3.4.2 Preparation of PTDH Mutant Constructs 
The mutants were prepared by the polymerase chain reaction (PCR) using QuikChange 
mutagenesis (Agilent).  The primers used to incorporate the mutations are provide below, along 
with their reverse complement strands, which are not shown: M53A: 5’-CG ATG ATG GCG 
TTC GCG CCC GAT CGG GTC G-3’; M53L: 5’-CG ATG ATG GCG TTC TTG CCC GAT 
CGG GTC– 3’; M53N: 5’-CAG GCG ATG ATG GCG TTC AAT CCC GAT CGG G-3’; 
M53L: 5’-CG ATG ATG GCG TTC TTG CCC GAT CGG GTC-3’. The mutated codon is 
underlined in each case. Once the mutant genes were constructed, they were sequenced in their 
entirety to ensure that the desired mutation was incorporated and no other mutations were 
generated. (JEH-4-38, JEH-4-53). 
 
3.4.3 Overexpression and Purification of PTDH Mutants  
Chemically competent E. coli BL21 (DE3) cells were transformed with plasmids containing the 
desired gene in pET15b and plated on a LB agar plate containing 100 µg/mL ampicillin. A single 
colony was picked and used to inoculate an overnight culture (50 mL). The cells were harvested 
by centrifugation, resuspended in 1 L of LB/ampicillin and grown at 37 °C to OD600 nm = 0.6. 
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IPTG was added to the culture (0.3 mM final concentration), which was incubated at 18 °C for 
16-20 h. Cells were then pelleted by centrifugation (8,000 × g, 30 min), resuspended in 20 mM 
Tris pH 7.6, 0.5 M NaCl, 10% glycerol (v/v), and stored at −80 °C. The frozen pellet was then 
thawed on ice and lysed using an Avestin Emulsiflex-C3 Homogenizer (7500 Psi,6 passes). The 
insoluble lysate was removed by centrifugation (15,000 × g, 30 min), and the soluble lysate was 
passed through a 0.44 μm filter. The enzyme was purified via FPLC (Äkta) by immobilized 
metal affinity chromatography (IMAC) with a HisTrap HP Ni2+-affinity column (GE Life 
Sciences).  The column was washed with 5 column volumes (CV) of buffer A, followed by a 
gradient to 40% buffer B over 5 CV, and another gradient of 2 CV to 100% buffer B. (Buffer A: 
20 mM Tris pH 7.6, 100 mM NaCl, 10 mM imidazole, 10% glycerol (v/v); buffer B: 20 mM Tris 
pH 7.6, 100 mM NaCl, 500 mM imidazole, 10% glycerol (v/v)). Fractions containing PTDH 
were identified by activity assay and analyzed by SDS-PAGE. The highly pure fractions were 
pooled and concentrated using centrifugal filtration (Amicon membrane, 30 kDa molecular 
weight cutoff; Millipore), followed by buffer exchange or dialysis to 20 mM MOPS pH 7.6, 100 
mM KCl, 10% glycerol. The protein solution was then flash frozen and stored at −80 °C. Protein 
concentration was determined using the calculated extinction coefficient for 17X-PTDH, 28,000 
M-1 cm-1 (3). All buffers used for SeMet PTDH preparation were supplemented immediately 
prior to use with 5 mM dithiothreitol (DTT) to prevent selenomethionine oxidation.  
 
3.4.4 Incorporation of Non-Proteinogenic Amino Acids into PTDH 
The method was adapted from (19). Methionine-auxotrophic E. coli (New England Biolabs, T7 
Express Crystal Competent) were transformed with plasmid encoding 17X-PTDH in pET15b 
(28) and plated on a LB agar plate containing 100 µg/mL ampicillin. A single colony was picked 
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and used to inoculate an overnight culture (50 mL) of M9 medium supplemented with  1 mM 
MgSO4, 0.1 mM CaCl2, 0.4% glucose, 1 µg/mL thiamine, 20 µg/mL of all proteinogenic amino 
acids, and 100 µg/mL ampicillin (hereafter called M9aa medium). The culture was grown at 37 
oC to stationary phase, and used to inoculate a 2 L culture of M9aa supplemented with 100 
µg/mL L-Met.  The culture was grown at 37 °C to OD600 nm = 0.6, sedimented (4500 × g, 10 min, 
4 °C), and the pellet resuspended in 0.9% NaCl (50 mL). This procedure was repeated three 
times to ensure complete removal of the original medium. The final pellet was resuspended in 2 
L M9aa lacking Met and grown for 20 to 30 min at 37 °C to deplete the remaining methionine 
within the cells. The cultures were cooled to 4 oC, supplemented with L-norleucine or L-
selenomethionine (300 µg/mL), induced with IPTG (0.3 mM final concentration), and grown 
overnight at 18 °C. Protein purification was then performed as detailed above. The purified 
protein was then analyzed by SDS-PAGE, digested with trypsin (G Biosciences) for Nle-PTDH 
or GluC (Roche) for SeMet-PTDH (1 U protease per 1 mg PTDH), and analyzed on a Synapt 
ESI quadrupole ToF Mass Spectrometry System (Waters) equipped with an Acquity Ultra 
Performance Liquid Chromatography (UPLC) system (Waters) or an ultrafleXtreme MALDI 
ToF system (Bruker Daltonics). The tryptic digest was performed in gel (21), while the GluC 
digest was performed in solution. GluC was used for the SeMet incorporation due to difficulty 
resolving the ions of the tryptic digest during mass spectrometry. The mass spectra obtained did 
not show peaks corresponding to incorporation of methionine in the tryptic peptide 45-
DAQAXXAFXPDR-56 or GluC-digested peptide 39-
ILRRCRDAQAXXAFXPDRVDADFLQACPE-67, where X refers to norleucine or 
selenomethionine, respectively (Figure 3.5). This observation indicates complete incorporation 
of the non-proteinogenic amino acid at the Met53 position. (JEH-4-56, JEH-7-73, JEH-7-100). 
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3.4.5 Steady-State Kinetic Assays 
The concentrations of NAD+ stock solutions were determined by the absorbance at 260 nm (ε = 
18,000 M-1 cm-1). The concentration of stock solutions of phosphite was determined by running 
the PTDH reaction to completion in the presence of excess NAD+. The maximum absorbance at 
340 nm was then measured, which represents the concentration of NADH formed (ε = 6.2 mM-1 
cm-1) and is equivalent to the concentration of phosphite consumed. Initial rates were determined 
using a Cary 4000 UV-vis spectrophotometer (Varian) to monitor the rate of formation of NADH 
using its absorbance at 340 nm (ε = 6.2 mM-1 cm-1). Typical reactions were performed in 100 
mM MOPS pH 7.25, 0.5-3.0 µM PTDH mutant, and holding either NAD+ or phosphite at 
saturating concentrations (20-50x KM) while varying the concentration of the other substrate. 
Reaction mixtures were allowed to equilibrate at 25 °C, as verified using a thermocouple, and the 
reaction was initiated by addition of enzyme. Assays were performed with the His6-affinity tag 
attached. The His-tag has been shown not to have a significant effect on kinetics of the enzyme 
in a previous study (29). The data were fit to the Michaelis-Menten equation using OriginPro 8 
(OriginLab). 
 
3.4.6 Synthesis of O-methyl Homoserine 
Boc-O-methyl-L-homoserine cyclohexyldiammonium salt (2.5 g, 6 mmol, Chem Impex) was 
dissolved in 47.5% CH2Cl2 (5 mL) and 47.5% TFA (5 mL), with 5% H2O (500 µL) as a cation 
scavenger. The reaction was stirred at room temperature for 1.5 h. The reaction was then purged 
with dry N2 to remove TFA and then evaporated to dryness using a rotary evaporator. Complete 
deprotection was observed by loss of the t-butyl peak by 1H NMR spectroscopy. A final yield of 
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105% was obtained, a 1:1 mixture of o-methyl homoserine and dicylohexylamine as determined 
by integration of the NMR peaks. 1H NMR (500 MHz, DMSO) δ 3.92 (m, 1H), 3.45 (t, 2 H), 
3.22 (s, 3H), 1.44 (d, 2H).  LRMS (ESI) calc. [M+H]+ for C5H12NO3 134.1, found 133.9. (JEH-7-
72). 
 
Scheme 3.1 
 
3.4.7 pH rate profile of Met53Ala 
Solutions of 100 mM Tris, 50 mM MES, and 50 mM AcOH, generating a universal buffer of 
constant ionic strength (30), were prepared at pH 4.3, 4.6, 4.9, 5.2, 5.5, 5.8, 6.1, 6.4, 6.7, 7.0, 7.3, 
7.6, 7.9, 8.2, 8.5, and 8.8. NAD+ stock solution was dissolved in buffer of desired pH and 
phosphite stock solutions were adjusted to the pH of the assay. NAD+ was held at presumed 
saturating conditions of 4 mM, while phosphite concentrations were varied. Reactions were 
mixed and allowed to equilibrate for several minutes under temperature control at 25° C and to 
ensure homogeneity until the baseline absorbance at 340 nm remained constant. Reactions were 
initiated by addition of Met53Ala (1.46 µM final concentration). Initial rates of NADH 
formation were monitored at 340 nm using a Cary 4000 spectrophotometer. Data were fit to the 
Michaelis-Menten equation using Origin 8 to obtain kinetic parameters. The data was then fit to 
Equations 2.2 and 2.3 to extract the pKa values for only the acidic and both the acidic and basic 
limbs, respectively. (JEH-5-75). 
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common probe of enzyme mechanism (8-10). With this in mind, attempts were made to mutate 
PTDH to accept thiophosphite as an alternative substrate through directed evolution.  
PTDH has been successfully engineered multiple times in the past; directed mutation allowed 
the enzyme to accept the alternative substrate NADP in addition to NAD+ (12), and PTDH has 
also been engineered to increase thermostability and activity through random mutagenesis (13-
15). These previous studies have afforded 17X-PTDH (13), a highly thermostable PTDH variant 
that has reduced cofactor specificity towards NADP. Given the high resilience and activity of 
this mutant, 17X-PTDH was selected as the template for further mutation to accept thiophosphite 
as a substrate through directed evolution.  
 
4.2 Results and Discussion 
4.2.1 Growth of E. coli on Thiophosphate-containing Media 
E. coli BW25141 was grown on MOPS minimal media plates with thiophosphate, phosphite 
or phosphate as the phosphorus source. The experiment was also performed with E. coli 
transformed with a plasmid encoding 17X-PTDH. As expected, growth was observed when 
phosphate was added, both with and without PTDH. In contrast, growth on phosphite was only 
seen when the bacteria were transformed with PTDH. Growth was also observed on 
thiophosphate under both conditions, although the phenotype of the colonies was slightly yellow. 
The magnitude of growth was comparable among all the plates. A negative control with no 
phosphorus source added yielded no visible colonies, as expected. This experiment showed that 
E. coli BW25141 can grow using thiophosphate as the sole phosphorus source. As thiophosphate 
would be the product of thiophosphite when reacted with PTDH, this experiment provided the 
impetus for further studies.  
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4.2.2 Synthesis of Thiophosphite 
Dibenzyl thiophosphite was successfully synthesized in 73% yield by reacting commercially 
available dibenzyl phosphite with Lawesson’s reagent (Scheme 4.1), in a procedure adapted from 
(16). The resulting compound was then deprotected by treatment with Na metal in NH3 and the 
resulting product contained thiophosphite as the sole phosphorus-containing molecule, as 
determined by 31P NMR spectroscopy (Figure 4.2). However, the dissolved metal reduction 
reaction resulted in 153% of the expected theoretical yield; this excess yield can likely be 
attributed to the presence of residual NaOH resulting from quenching of the sodium metal. 
Attempts to further purify thiophosphite by recrystallization were unsuccessful, and purification 
through ion exchange chromatography is currently being attempted. Attempts to deprotect 
dibenzyl thiophosphite via other methods that might result in fewer byproducts, including high 
pressure hydrogenation and treatment with BBr3, were unsuccessful.  Although the thiophosphite 
was not fully pure, further studies were attempted as thiophosphite was observed to be the sole 
contributor of phosphorus according to the 31P NMR analysis.   
 
 
 
Scheme 4.1 
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Figure 4.2. 31P NMR analysis of purified (A) dibenzyl thiophosphite and (B) sodium 
thiophosphite. 
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 4.2.3 Development and Screening of an Error-Prone Library of PTDH Mutants 
A library of PTDH mutants was prepared using error-prone PCR. To increase the mutation 
rate, Taq polymerase was used with unbalanced concentrations of dNTPs (17) and the addition 
of MnCl2 (18). MnCl2 concentrations were varied between 0.15, 0.30, and 0.60 mM, with the 
goal of obtaining a library with differing numbers of total mutations per gene. Overall, a total 
library size of ~ 105 mutant PTDHs was successfully obtained.  
However, when two individual mutants were sequenced from each experiment with different 
concentrations of mutagen, the number of mutations obtained was not consistent with what was 
expected (Table 4.1). Although it has been reported (13) that 0.2 mM MnCl2 would introduce 1 
to 2 amino acid mutations in a 1000 base pair (bp) plasmid, we observed a different mutation 
rate. However, these results may simply be a result of insufficient sample size. Alternatively, it is 
possible that combining MnCl2 with the unbalanced pool of dNTPs increased the mutation rate to 
an unexpected degree.  
 
Table 4.1. Mutation rate in the PTDH Library 
MnCl2 concentration Number of Mutations 
0.15 mM 7 
0.15 mM 7 
0.30 mM 2 
0.30 mM 3 
0.60 mM 9 
0.60 mM 3 
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When the mutant PTDH library obtained at each mutagen concentration was screened on 
minimal media plates with thiophosphite as the sole phosphorus source, dozens of small colonies 
(>100) were observed. Interestingly, the size of these colonies was considerably smaller than the 
colonies that were observed for the positive controls with phosphate or phosphite. Unexpectedly, 
some growth by E. coli on the negative control plates that had no phosphorus source added was 
also observed. However, fewer of these colonies were observed, and their growth phenotype was 
somewhat smaller than that observed for the thiophosphite plates. In addition, these colonies did 
not appear to continue growing as incubation time was increased. It is likely that some small 
amount of phosphorus contamination was present in the media, as has been observed previously 
(19). Interestingly, similar small colonies were observed when E. coli containing the parent 17X-
PTDH was grown on thiophosphite plates. This observation may be caused by residual 
phosphorus contamination, or alternatively 17X-PTDH may have slight activity on 
thiophosphite, though this is not supported by in vitro assays (see below) and it has previously 
been reported that wt-PTDH lacks activity on thiophosphite (2). 
Several of the mutant colonies that were able to grow on thiophosphite were inoculated into 
liquid LB culture, grown, and plated again on thiophosphite plates to verify that they indeed had 
activity. Interestingly, these colonies were also able to grow on phosphite, suggesting that the 
mutant PTDHs may retain the ability to accept the original substrate. The plasmids of mutants 
that were able to successfully grow on thiophosphite were extracted, and the mutant PTDH genes 
were subcloned into pET15b for future analysis, which will be performed by Katarzyna Dubiel.  
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4.2.4 Test of In Vitro Activity of PTDH Against Thiophosphite 
When 17X-PTDH was tested against the partially purified thiophosphite, an apparent 
increase in the absorbance at 340 nm (corresponding to NADH formation) was observed over 
time, with a very slow rate. While this appeared at first glance to indicate that 17X-PTDH 
accepts thiophosphite as a substrate, further analysis suggests that this is not the case. 31P NMR 
analysis showed that no thiophosphate was being produced, and absorbance scans showed that a 
peak at 326 nm grew in over time upon mixing of thiophosphite, NAD+, and PTDH, as opposed 
to 340 nm. This data suggests that the enzyme is not turning over when thiophosphite is used as 
the substrate; it is instead likely that some sort of adduct is forming between NAD+ and 
thiophosphite. The mutant PTDHs have not yet been tested in vitro; it is possible that mutations 
may allow the enzyme to avoid this phenomenon and turn over thiophosphite.  
 
4.3 Conclusions and Outlook 
In this study, I successfully synthesized thiophosphite and created a mutant library of PTDHs 
through error-prone PCR. This library was then screened for the possibility that E. coli was 
endowed with the ability to grow on thiophosphite as the sole phosphorus source, and it appears 
that several PTDH mutants may have gained the ability to utilize thiophosphite based on their 
successful growth on this media. Several of these mutants have been cloned into expression 
vectors for future analysis by in vitro assay.  
Although we appear to have successfully generated PTDH mutants that have activity with 
thiophosphite in vivo, further characterization will be needed. In particular, the mutant proteins 
will need to be purified and tested against thiophosphite in vitro. However, in order to perform 
accurate kinetics assays, the thiophosphite compound will need to be fully purified, or at least 
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further characterized to determine the exact amount of thiophosphite in the product. These efforts 
are currently underway and are being attempted by Katarzyna Dubiel. If directed evolution fails 
to yield a PTDH capable of utilizing thiophosphite, one possible alternative is to test other 
known PTDH orthologs (5, 20, 21) for activity. If mutation of PTDH to accept the alternate 
substrate is successful, it may be possible to analyze the stereochemistry of the PTDH reaction in 
future studies by using chiral substrates. Another set of experiments that would reveal important 
details about the PTDH reaction are heavy atom isotope effects (22). Determining the kinetic 
isotope effect of PTDH when reacted with 18O-labeled phosphite would allow for further insight 
into the mechanism of phosphoryl transfer.  
 
4.4 Materials and Methods 
4.4.1 Materials and General Methods 
This study was performed with the assistance of an undergraduate student, Katarzyna Dubiel 
(referred to as KD in references below). All chemicals were obtained from Sigma or Aldrich and 
used without further purification. E. coli BW25141 was donated by the Metcalf lab (Δ(araD-
araB)567, ΔlacZ4787(::rrnB-3), Δ(phoB-phoR)580, λ-, galU95, ΔuidA3::pir+, recA1, endA9(del-
ins)::FRT, rph-1, Δ(rhaD-rhaB)568, hsdR514). This strain contains a phoBR(-) phenotype to 
prevent the phosphate starvation response, ΔaraBAD to prevent arabinose metabolization, and 
the encodes the pir gene, which allows replication of plasmids with the R6K origin of replication 
(15, 23). pRW2 plasmid containing 17X-PTDH was donated by the Zhao lab. This plasmid 
contains 17X-PTDH under an arabinose promoter, and uses the R6K origin of replication, 
making it compatible with E. coli BW25141 (12). In vitro activity experiments were performed 
as detailed in section 2.4.6.  
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4.4.2 Synthesis of Thiophosphite 
Dibenzyl phosphite (1.66 g) was dissolved in benzene, and Lawesson’s reagent was added (1.2 
equivalents, 1.53 g). The reaction was heated at 80 °C for 1 h until the Lawesson’s reagent 
(yellow solid) was no longer observed. TLC analysis (CH2Cl2) indicated that the product was 
formed (Rf = 0.95). The reaction mixture was concentrated by rotary evaporator and purified by 
passing through a silica column (CH2Cl2). The resulting crude product was dissolved in toluene 
and the solvent was removed by evaporation (2x), and the residue was placed on a vacuum line 
overnight. 31P NMR analysis (400 MHz, CDCl3) showed peaks corresponding to dibenzyl 
thiophosphite δ71.3 ppm (d,p, J = 695, 12 MHz) (Figure 4.2A). The final yield was 73%. No 
dibenzyl phosphite starting material was observed in the 31P NMR analysis (δ9.1 ppm, d,p J = 
744, 11 MHz).  
 
The deprotection setup was dried by flame under vacuum and purged with nitrogen. About 30 
fold excess (~0.45 g) freshly cut Na metal was added to the flask, and NH3 (10 mL) was 
condensed into the flask while in an acetone/dry ice bath. The vacuum-dried dibenzyl 
thiophosphite (0.16 g) was dissolved into dry diethyl ether (5 mL) and added to the reaction. The 
solution was allowed to stir for 10 min. The reaction was quenched with 20 mL of dry methanol 
and the flask purged with nitrogen gas to evaporate the NH3. The sample was then extracted with 
chloroform and water (20 mL each), and the water layer was lyophilized to dryness. The product 
contained only peaks corresponding to the sodium salt of thiophosphite when analyzed by 31P 
NMR spectroscopy (400 MHz, D2O): δ37.5 (d, J = 582 Hz) (Figure 4.2B). Mass spectrometric 
analysis (ESI, negative mode) shows ions with expected mass of thiophosphite (m/z = 97). Yield 
= 153%; the product is likely contaminated by excess NaOH from the methanol quench of excess 
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sodium and subsequent hydrolysis with water.  Attempts to further purify the compound using 
recrystallization have thus far been unsuccessful. (JEH-7-89, JEH-7-83, JEH-7-84, JEH-7-91).  
 
4.4.3 Growth of E. coli on Thiophosphate  
Plates were composed of autoclaved MOPS minimal media (24) (Teknova) with 1.6% highly 
pure Noble agar (Affymetrix), supplemented with 0.2% glucose and 1.0 mM arabinose (sterile 
filtered). Then each phosphorus source was added (1.0 mM), consisting of phosphite, 
thiophosphate, phosphate (positive control), or no phosphorus (negative control). Plates were 
streaked with E. coli BW25141, with or without the pRW2 plasmid containing the 17X-PTDH 
gene. The plates were also supplemented with kanamycin (50 µg/mL) for E. coli containing the 
pRW2 plasmid. Growth was determined after 48 h at 37 °C. (JEH-7-69).  
 
4.4.4 Development of Error-prone PCR Library 
The protocol to develop the error-prone PCR library was adapted from (13, 15). Error prone 
PCR was performed by using Taq polymerase ( Invitrogen) in the presence of Mn2+ while 
varying dNTP concentrations to increase the error rate (18). The PTDH gene was amplified from 
pRW2 plasmid using the following primers: 5’–CGG GAA GAC GTA CGG GGT ATA CAT 
GT–3’ (with PciI restriction site underlined), and 5’–TTT TTG GAT GGA GGA ATT CAT 
ATG–3’ (with NdeI restriction site underlined). The typical PCR reaction contained Taq buffer, 
50 ng template plasmid, 0.5 µM each primer, 6 mM MgCl2, 0.2 mM dATP and dGTP, 1.0 mM 
dTTP and dCTP, 5 units of Taq, and 0.15, 0.30, or 0.60 mM MnCl2 in 50 µL reaction volume. 
The reaction was cycled 20 times through melting, annealing, and extension temperatures of 95, 
55, and 72 °C, respectively. The reaction product was then sequentially digested with DpnI, 
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NdeI, and PciI. The product was run on agarose gel and verified to be the expected ~ 1000 bp, 
following which the DNA was extracted using a QIAquick Gel Extraction kit (Qiagen). The 
insert DNA was ligated overnight at 16 °C with NdeI and PciI-digested pRW2 plasmid. The 
resulting ligation product was extracted by butanol (500 µL), dried, and resuspended into sterile 
water (10 µL). When the library DNA was transformed, a total library size of ~ 105 was 
obtained. (KD-01-57, KD-01-60). 
 
4.4.5 Screening of the Thiophosphite Mutant Library 
MOPS minimal media plates were prepared (see section 4.4.3) with 0.5 mg/mL partially 
purified thiophosphite (see section 4.4.2) as the sole phosphorus source. Aliquots of highly 
electrocompetent E. coli BW25141 were transformed with the error-prone library of PTDH 
according to standard transformation protocol. Following recovery in SOC media (New England 
Biolabs), the transformed library cells were sedimented and washed with MOPS minimal media 
with no phosphorus added (2x) to remove residual phosphorus. The cells were then plated and 
grown for ~ 48 h at 37 °C. Colonies that successfully grew on the thiophosphite media were used 
to inoculate a 5 mL LB culture, grown, and the DNA extracted using a Miniprep kit (Qiagen). 
The plasmid was then digested by BamHI and NdeI and the digested insert was ligated into 
pET15b. (KD-01-73, KD-01-74).  
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APPENDIX A: INVESTIGATION INTO POSSIBLE COVALENT CATALYSIS BY 
PTDH 
 
A.1 Introduction 
Protein phosphorylation events are very common in all domains of life. Serine/threonine and 
tyrosine kinases are well characterized and are commonly used in signal transduction pathways 
(1). Another common post-translational modification that is frequently overlooked is 
phosphorylation of histidine residues, which can occur at both the Nε2 and Nδ1 nitrogen sites 
(Figure A.1) (2). It is estimated that this type of phosphorylation may make up as much as 6% of 
total phosphorylation in eukaryotes (3), and that it is as much as 10- to 100-fold more abundant 
than tyrosine phosphorylation (4). They are also common in two-component signaling pathways 
in prokaryotic systems, which consist of a histidine kinase and a regulator protein which receives 
the phosphate. This family of proteins encodes ~1% of encoded proteins in eubacteria (5). A 
number of crystal structures of enzymes containing these phosphorylated histidines have been 
published (6-8), and the phosphohistidine adduct is observed in the X-ray structures. However, 
this adduct is highly acid labile, and as such mass spectrometric (MS) analysis, the standard tool 
in proteomic detection, is difficult (2, 9, 10). Recently, however, methods to detect the presence 
of phosphohistidine through mass spectrometric (9, 11) and NMR (12) methods have been 
developed.  
 
Figure A.1. Histidine phosphorylated at the Nε2 nitrogen, the likely modification site in PTDH, 
if the enzyme uses a covalent modification 
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An alternative mechanism in PTDH catalysis to the direct nucleophilic attack of water or 
hydroxide onto phosphite (regardless of whether this occurs through a concerted, associative, or 
dissociative mechanism) is a covalent catalysis mechanism. In such a case, a residue in the 
PTDH active site would covalently attack the phosphite substrate, yielding a covalent 
phosphohistidine intermediate following hydride transfer to NAD+ (Figure A.2). This 
intermediate would then be hydrolyzed, with the enzyme utilizing another residue to act as the 
base to deprotonate the water nucleophile, yielding the free enzyme and final products. In the 
crystal structure, His292 could potentially act in this fashion, as the ε2 nitrogen on the imidazole 
ring is 3.7 Å from the sulfur of sulfite in the ternary complex (see Figure 2.2). In an attempt to 
determine if a covalent catalysis mechanism is being utilized by PTDH, the presence of a 
phosphohistidine intermediate was investigated using mass spectrometric analysis.  
 
Figure A.2. A covalent catalysis mechanism for PTDH, with His292 as the nucleophile.  
 
A.2 Results and Discussion 
A.2.1 Investigating Formation of a Phosphohistidine Covalent Adduct 
The possibility of a covalent catalysis mechanism was investigated by probing for a 
phosphohistidine intermediate. Although the phosphohistidine adduct is highly acid labile, 
methods have been developed to detect its presence through MS by iodinating all the unprotected 
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histidines, leaving only the phosphorylated histidine unmodified (9). Following in vitro reaction 
of PTDH with saturating amounts of NAD+ and phosphite, the enzyme was denatured by 
exposure to guanidinium hydrochloride while excess substrate was still present (i.e. the enzyme 
remained under kcat conditions). The mixture was then digested by trypsin and iodinated to 
covalently modify accessible tyrosine and histidine residues. If present, the phosphohistidine 
intermediate would protect histidine from iodination by occupying its lone pair electrons, and 
acidification prior to mass spectrometric analysis would lead to an unmodified residue, as the 
adduct is acid labile (9). For both 17X-PTDH and R301A-PTDH, however, the MS of the 
samples with and without phosphite added (a negative control incapable of forming the 
phosphohistidine adduct) were almost identical by MALDI-MS (Figure A.3 shows the data for 
17X-PTDH, the spectra for the R301A mutant are similar) The expected tryptic peptide 271–
ADRPQQIDPALLAHPNTLFTPHIGSAVR–298 has two sites capable of being iodinated, both 
histidines as indicated in bold. The expected mass for the singly- and doubly-iodinated species 
are M+H = 3161 and 3287. Very low intensity ions for single iodination are observed in both the 
experimental and negative controls, which likely correspond to incomplete iodination unrelated 
to the presence of the adduct. MS spectra of the reaction mixture prior to iodination (where the 
phosphohistidine adduct would be the expected modification at M+H = 3116, umodified M+H = 
3035) also failed to yield ions that would indicate the presence of a phosphohistidine adduct.   
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Figure A.3. MALDI-MS spectra of the tryptic fragment of 17X-PTDH containing His292. (A) 
17X-PTDH with phosphite, (B) negative control of 17X-PTDH without phosphite, and (C) 
reaction mixture without iodination.  
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In the case of covalent catalysis by His292, Arg301 would be the most likely candidate for 
the catalytic base to deprotonate water for attack on the phosphoryl group. Thus, removal of the 
arginine functional group, as in R301A, would likely lead to slower turnover of the 
phosphohistidine adduct and therefore a greater likelihood to observe the intermediate. However, 
for both 17X-PTDH and R301A, the trypsin-digested peptide fragments containing His292 were 
observed to be predominantly iodinated and identical to the negative control reactions performed 
without phosphite, suggesting that phosphohistidine was not present to protect the residue from 
iodination. This data suggests that a covalent catalysis mechanism does not occur, although it 
cannot be ruled out that the phosphohistidine intermediate was formed in amounts too small to 
be accurately detected by mass spectrometry and differentiated from the negative control using 
this method.  
 
A.3 Conclusions 
Overall, the mass spectrometry data shows that phosphohistidine not was present in the 
PTDH sample, suggesting that a covalent catalysis mechanism using His292 as the nucleophile is 
unlikely. Although the enzyme was fully saturated in substrate and acting under kcat conditions 
and therefore should have had the maximum possible occupancy in the intermediate state, it 
remains possible that the catalytic amount of intermediate may be below the detection limit of 
this method. As such, the possibility that PTDH utilizes a covalent catalysis mechanism cannot 
be completely ruled out.   
At present, no direct experimental evidence is available to suggest that PTDH utilizes a 
covalent catalysis mechanism. PTDH has no sequence homology with known histidine kinases, 
and available data suggests that His292 acts as a base rather than a catalytic nucleophile (see 
Chapter 2). Furthermore, since Arg301 appears to act in electrostatic catalysis as a positively 
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charged residue, no other obvious conserved residues in the active site could act as the catalytic 
base (see Figure 2.2). Therefore, it is more likely that His292 acts as the catalytic base in the 
reaction, as opposed to the PTDH reaction occurring through covalent catalysis.  
 
A.4 Materials and Methods 
A.4.1 Investigation of the Phosphohistidine Adduct 
The method was adapted from (9). The PTDH reaction was allowed to proceed for 2 min under 
saturating conditions of both substrates at room temperature to allow for potential 
phosphohistidine formation (Conditions: 100 mM Tris pH 7.3, 4 mM NAD, 100 mM phosphite, 
7.3 nmol 17X-PTDH or R301A-PTDH in 200 µL). The reaction was quenched by addition of 2 
mL denaturing solution (12 M guanidinium hydrochloride, 50 mM Tris pH 8.5, 10 mM DTT) 
and incubated at 55 °C for 1 h. Then 3 equivalents of iodoacetamide were added (175 nmol, to 
label the 8 Cys residues in PTDH) and the reaction was incubated in the dark at 55 °C for 1 h. 
The mixture was then diluted to 10 mL with water to dilute the denaturant, and trypsin was 
added (1:50 ratio of protease to protein). The reaction mixture was incubated at 37 °C overnight. 
The sample was then desalted with a C4 solid phase extraction column (Vydac) using the 
supplied protocol, with the exception that trifluoroacetic acid (TFA) concentration was reduced 
to 0.01% to slow phosphohistidine decomposition (4). The sample was immediately lyophilized 
(overnight) to remove TFA. The samples were then reconstituted to 50 mM Tris pH 9.2, 2 mM 
NaI (1 mL).  
A fresh I2 solution was prepared by addition of Chloramine T solution (330 nmol, a 2.5 
stoichiometric excess of the iodable His and Tyr residues on PTDH, 1 mL) to the NaI solution 
(1320 nmol, 4-fold excess to Chloramine T, 2 mL) followed by mixing for 10 min. The resulting 
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I2 solution was added to the digested PTDH solution in the dark (6 aliquots of 0.5 mL, added 
every 10 min). The reaction was allowed to proceed for an extra 30 min and was mixed with 1.5 
equivalents Na2S2O5 to quench the excess I2. The reaction mixture was desalted by C4 SPE 
column and then analyzed by MALDI mass spectrometry (Bruker Ultraflex). (JEH-6-15) 
 
A.5 References 
1. Pawson, T., and Scott, J. D. (2005) Protein phosphorylation in signaling – 50 years and 
counting, Trends Biochem. Sci. 30, 286-290. 
2. Puttick, J., Baker, E. N., and Delbaere, L. T. J. (2008) Histidine phosphorylation in 
biological systems, Biochim. Biophys. Acta 1784, 100-105. 
3. Matthews, H. R. (1995) Protein kinases and phosphatases that act on histidine, lysine, or 
arginine residues in eukaryotic proteins: A possible regulator of the mitogen-activated 
protein kinase cascade, Pharmacol. Ther. 67, 323-350. 
4. Klumpp, S., and Krieglstein, J. (2002) Phosphorylation and dephosphorylation of 
histidine residues in proteins, Eur. J. Biochem. 269, 1067-1071. 
5. West, A. H., and Stock, A. M. (2001) Histidine kinases and response regulator proteins in 
two-component signaling systems, Trends Biochem. Sci. 26, 369-376. 
6. Oberholzer, A. E., Schneider, P., Siebold, C., Baumann, U., and Erni, B. (2009) Crystal 
structure of Enzyme I of the phosphoenolpyruvate sugar phosphotransferase system in 
the dephosphorylated state, J. Biol. Chem. 284, 33169-33176. 
7. Bond, C. S., White, M. F., and Hunter, W. N. (2001) High resolution structure of the 
phosphohistidine-activated form of Escherichia coli cofactor-dependent phosphoglycerate 
mutase, J. Biol. Chem. 276, 3247-3253. 
 114 
 
8. Lott, J. S., Paget, B., Johnston, J. M., Delbaere, L. T. J., Sigrell-Simon, J. A., Banfield, 
M. J., and Baker, E. N. (2006) The Structure of an Ancient Conserved Domain 
Establishes a Structural Basis for Stable Histidine Phosphorylation and Identifies a New 
Family of Adenosine-specific Kinases, J. Biol. Chem. 281, 22131-22141. 
9. Sun, Q., and Julian, R. R. (2011) Probing sites of histidine phosphorylation with 
iodination and tandem mass spectrometry, Rapid Commun. Mass Spectrom. 25, 2240-
2246. 
10. Besant, P., and Attwood, P. (2009) Detection and analysis of protein histidine 
phosphorylation, Mol Cell Biochem 329, 93-106. 
11. Kleinnijenhuis, A. J., Kjeldsen, F., Kallipolitis, B., Haselmann, K. F., and Jensen, O. N. 
(2007) Analysis of histidine phosphorylation using tandem MS and ion−electron 
reactions, Anal. Chem. 79, 7450-7456. 
12. Himmel, S., Wolff, S., Becker, S., Lee, D., and Griesinger, C. (2010) Detection and 
Identification of Protein-Phosphorylation Sites in Histidines through HNP Correlation 
Patterns, Angew. Chem. Int. Ed. 49, 8971-8974. 
 
 
 
 
